Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Results for the year ended 31 December 2024

14th Apr 2025 07:00

RNS Number : 8608E
Aquis Exchange PLC
14 April 2025
 

14 April 2025

Aquis Exchange PLC

("Aquis", the "Company" or the "Group")

Results for the year ended 31 December 2024

Aquis, the creator and facilitator of next generation financial markets, is pleased to announce its audited results for the year ended 31 December 2024.

 

Financial highlights:

FY24 (£m)

FY23 (£m)

Gross revenue

23.8

23.7

Net revenue

20.1

22.7

Adjusted profit before tax*

1.1

5.2

(Loss) / profit before tax

(2.2)

5.2

Basic (Loss) / Earnings per share (p)

(9)p

19p

Cash and cash equivalents

13.7

14.8

 

*Alternative performance measures have been used to ensure comparability of financial information between reporting periods. Costs related to the Recommended Offer (defined below) have been treated as exceptional items as they are neither related to the ongoing activities of the Group, nor are they repeatable expenditures.

 

Business highlights:

- Aquis continued to execute its ambitious long-term strategy, achieving key milestones in all divisions, despite continuing macroeconomic challenges.

- Aquis Markets launched conditional orders early in 2024, with subsequent fast growth in use of the product helping to increase market share to 5.22% (HY24: 5.20%).

- Aquis Technologies saw continued interest from a diverse mix of prospective clients in the division's pioneering exchange technology, with one new contract signed and strong growth in the division's contract pipeline to stand at record levels.

- Aquis Data saw further strong growth in market data revenues, following a full year of member data fees and the onboarding of five new clients.

- Aquis Stock Exchange delivered positive growth in trading volumes along with the highest levels of secondary fundraising since acquisition, despite the continuing UK-wide depressed levels of primary listings.

 

Recommended Cash Offer for Aquis by SIX Exchange Group AG

On 11 November 2024, the boards of SIX Exchange Group AG ("SIX") and Aquis were pleased to announce that they had reached agreement on the terms of a recommended cash offer to be made by SIX for the entire issued and to be issued ordinary share capital of Aquis (the "Recommended Offer"), to be implemented by way of a court-sanctioned scheme of arrangement under Part 26 of the Companies Act 2006 (the "Scheme").

As previously announced, the requisite majorities of Aquis shareholders voted in favour of the Scheme and approved all shareholder resolutions relating to the Recommended Offer at a Court Meeting and General Meeting held on 20 December 2024.

The Scheme remains subject to the satisfaction (or waiver, where applicable) of certain conditions, including the receipt of certain regulatory approvals and subsequent sanction of the Scheme by the High Court of Justice; full details of the conditions can be found in Part III of the Scheme Document. Presently, Aquis has obtained all of the approvals required to satisfy the antitrust conditions. The remaining conditions, which relate to regulatory approvals, are expected to be satisfied in Q2 2025, and the Scheme remains expected to become effective in Q2 2025 and, in any event, prior to 11 November 2025.

 

David Stevens, CEO, Aquis Exchange PLC, said:

"2024 was a year of strategic progress for Aquis across the Group, with a slight increase in gross revenue despite continued economic headwinds throughout the year.

"The Group benefits from the diversified product offerings of its four divisions, with growth in the Markets and Data divisions offsetting a flat year for the Aquis Stock Exchange and a decline in revenues for the Technologies division following a strong 2023.

"I am proud of the achievements of our team across market share, technology innovations, new contracts and strengthening of the primary market. The Recommended Offer represents an exciting next step in Aquis' journey and an opportunity to accelerate our development. I remain confident in Aquis' ability to create and facilitate better markets for a modern economy."

 

 

Enquiries:

 Aquis Exchange PLC

David Stevens, CEO

Richard Fisher, CFO and COO

Adele Gilbert, Chief Communications Officer

 

Tel: +44 (0)20 3597 6329

[email protected] 

Investec Bank plc (Nominated Adviser and Broker)

David Anderson

St John Hunter

 

Tel: +44 (0)20 7597 5970

Canaccord Genuity Limited (Joint Broker)

Emma Gabriel

George Grainger 

 

 Tel: +44 (0) 20 7523 8000

 

VSA Capital Limited (AQSE Corporate Adviser)

Andrew Raca

 

Tel: +44 (0 )20 3005 5000

 

MHP Group (Financial PR Adviser)

Eleni Menikou

Finn Taylor

Tel: +44 (0) 20 3128 8000

[email protected]

 

 

About Aquis Exchange PLC

Aquis Exchange PLC ("Aquis") is Europe's challenger exchange, creating better markets for a modern economy. Aquis has market-leading technology and innovative rules for trading, and offer primary listings and secondary trading of equities, along with global licensing of proprietary technology.

Aquis consists of four divisions:

Aquis Markets operates lit and dark order books, covering 16 European markets. For its lit books, Aquis uses a subscription pricing model which works by charging users according to the message traffic they generate, rather than a percentage of the value of each stock that they trade.

Aquis Technologies is the software and technology division of Aquis. It focuses on building better markets via the creation and licensing of cutting-edge, cost-effective exchange infrastructure technology and services, including matching engine and trade surveillance solutions.

Aquis Stock Exchange (AQSE) is a stock market providing primary and secondary markets for equity and debt products. It is authorised as a Recognised Investment Exchange, which allows it to operate a regulated listings venue. The AQSE Growth Market is divided into two segments 'Access' and 'Apex'; the Access market focuses on earlier stage growth companies, while Apex is the intended market for larger, more established businesses.

Aquis Data generates revenue from the sale of data derived from Aquis Markets and Aquis Stock Exchange to market participants.

Aquis is authorised and regulated by the UK Financial Conduct Authority and France's Autorité de contrôle prudentiel et de résolution and L'Autorité des marchés financiers to operate Multilateral Trading Facility businesses in the UK & Switzerland markets and in EU27 markets respectively. Aquis Exchange PLC is quoted on the Aquis Stock Exchange and on the AIM Market (AIM) of the LSE. For more information, please go to www.aquis.eu.

 

Chair's Statement

It was with great pleasure that I assumed the role of Chair of Aquis Exchange PLC (AQXE) in 2024, and I am pleased to be reporting a year of strategic progress.

Thank you to my predecessor, Glenn Collinson, for his prior leadership of the Board.

During 2024, Aquis benefited from the diversified nature of its businesses, with key milestones reached across all divisions and significant progress made towards strategic objectives, despite the continued challenges of the economic and markets backdrop. Overall, gross revenue remained flat at £23.8m, with net revenues decreasing due to increased credit provisions against two technology contracts as well as the non-renewal of a contract with a start-up exchange, as previously communicated.

Overview

2024 was an important year for Aquis, as we continued to facilitate and operate better markets for a modern economy in the UK and across Europe. The Group continued to make progress, underpinned by strategic development in each of our four business activities: Markets, Technology, Data and the Aquis Stock Exchange. The strategic progress of the business is particularly noteworthy given the difficult conditions which the economic and markets environments have faced since 2021, which showed little improvement over the period.

Gross revenue for the year was broadly flat with a 0.3% increase on 2023 to £23.8m and adjusted profit before tax falling to £1.1m. Building on 2023 performance, strategic milestones were met across all divisions and revenue was particularly strong in Aquis Markets, with increasing contributions from the Aquis dark pool (AMP) and the new conditional order type, as well as increased revenue from market data following a full year of charging members. We continued to develop our presence in Europe and enhance client relationships within the EU 27 markets.

Board and Governance

Jonathan Clelland retired from the Board in April 2024, as planned and previously announced in the 2023 report. Glenn Collinson stepped down from the Board for personal reasons in November 2024, at which point I was appointed to the position of Chair. Following this change, I stepped down from the Audit, Risk & Compliance Committee and Ruth Wandhöfer joined the Nominations and Remuneration Committee.

In February 2025, Chief Executive Alasdair Haynes made the decision to step away from full-time running of the business due to health reasons. I would like to take this opportunity to thank Alasdair for the enthusiasm and vision with which he founded Aquis and led the company for 13 years, and I am delighted to have Alasdair remaining with Aquis as the Group President and on the Board as a Non-Executive Director. The Board was pleased to appoint David Stevens, the Group's prior Chief Operating Officer (COO), into the CEO role and to see the positive reception by the broader business. In addition to his role as Chief Financial Officer, Richard Fisher has assumed the role of COO.

We believe the Board is scaled appropriately to meet the opportunities ahead, however, we will continue to monitor closely the skills and experience of the Board to ensure that we are able to steer the business to continue to deliver on all aspects of its strategy.

Culture, Stakeholder Engagement and Section 172 Duties

The Board continued its engagement with key stakeholders, particularly focusing on employees and shareholders.

Executive management meet with the key shareholders at appropriate times during the year and provide feedback to the Board, and I, and previously Glenn Collinson, and the Chair of the Nomination & Remuneration Committee continued, where possible, to engage with shareholders through one-on-one meetings. Shareholders have been appreciative of these meetings and feedback is provided to the Board in both written and verbal updates.

The Group promotes a positive and inclusive culture. Team meetings and Group briefings are held on a regular basis to ensure all personnel are informed of the Group's performance and key strategic objectives and goals. Staff are encouraged to contribute to a monthly employee engagement pulse survey, which allows employees to provide feedback in confidence, the results of which were consistently positive during the year. The Executive team develops an action plan to address the key areas highlighted with particular emphasis on our core values, listed later in this report, and on investing further in employee training and career development.

Environment, Social and Corporate Responsibility

From the outset, Aquis has been committed to improving the efficiency of markets through transparency and innovation. In addition, we aim to stimulate growth in the economy by listening to the needs of issuers and creating a supportive, fair and low-cost environment for capital raisers to list instruments, particularly for innovative young companies. These initiatives have wide corporate and social benefits in addition to helping to build Aquis' business.

We continue to make progress on our ESG plans by measuring our carbon footprint and have set a target to reduce our environmental impact. In addition, we continued our financial literacy community project and increased our staff engagement efforts, reflecting the continued growth of the organisation. Details of these initiatives and workplace culture award recognition are set out in the Strategic Report.

Our Board in 2025 comprises three women and five men. We will continue to build the best teams at Aquis irrespective of peoples' gender, religion, ethnicity or any other factor that is not relevant to the job in hand. We use the Gender Pay Gap measure as an objective way of measuring the level of female seniority in the company. We remain committed to further improving the measure of female seniority; in 2024 this was 16% on base salary and 19% on base salary plus annual bonus, an improvement on 20% and 23% respectively last year. Our target remains to be materially better than the average in UK financial services (25.1%) on this measure.

The Recommended Offer

On 11 November 2024, we were pleased to announce that Aquis had reached agreement with SIX Exchange Group AG ("SIX") on the terms of a recommended cash offer to be made by SIX to acquire the whole of the issued and to be issued share capital of Aquis (the "Recommended Offer"), to be implemented by way of a court-sanctioned scheme of arrangement under Part 26 of the Companies Act 2006 (the "Scheme").

The requisite majorities of Aquis shareholders voted in favour of the Scheme and approved all shareholder resolutions relating to the Recommended Offer at a Court Meeting and General Meeting held on 20 December 2024.

The Scheme remains subject to the satisfaction (or waiver, where applicable) of certain conditions, including the receipt of certain regulatory approvals and subsequent sanction of the Scheme by the High Court of Justice; full details of the conditions can be found in Part III of the Scheme Document. Presently, Aquis has obtained all of the approvals required to satisfy the antitrust conditions. The remaining conditions, which relate to regulatory approvals, are expected to be satisfied in Q2 2025, and the Scheme remains expected to become effective in Q2 2025 and, in any event, prior to 11 November 2025.

Following satisfaction of the outstanding regulatory conditions, an updated timeline with expected principal dates will be notified to shareholders by announcement through the Regulatory Information Service.

The Scheme Document can be viewed at www.aquis.eu/investors/offer-documentation.

Our focus for the year ahead

We are confident that we have the resources and technology to support further growth across all our business activities and we will continue to invest in order to maintain this trajectory.

Deirdre Somers

Chair

Chief Executive's Report

Overview

2024 was a year of strategic progress for Aquis with gross revenues of £23.8m, a 0.3% increase on 2023.

This was achieved despite continuing economic headwinds throughout the year, and factors like political change (both in the UK and abroad), interest and inflation rates impacting on market conditions and primary market issuances.

Adjusted profit before tax decreased by £4.1m to £1.1m due to the previously announced increased credit provisions against two technology contracts as well as the non-renewal of a contract with a start-up exchange.

However, the Group benefited from the diversified product offerings of its four divisions, with growth in the Markets and Data divisions offsetting a flat year for the Aquis Stock Exchange and a decline in revenues for the Technologies division following a strong 2023 and the adjustment in ECL provisions. All four divisions made significant progress against the strategy over the period, and I am pleased with the trajectory of each and continued strength of our principal business activities.

The Group's balance sheet remains strong and the business is well-capitalised for future opportunities.

Aquis Markets

Over the period, the secondary market multilateral trading facility ("MTF") platforms operated by the Group in London and Paris continued to grow despite challenging economic and regulatory conditions, underpinning the resilience of the subscription model. Divisional revenue increased to £11.8m, up 7.8%.

Aquis had a 5.11% share of total trading on exchange in 2024, and ended December with a market share of 5.22%: a 0.25% increase year-on-year.

In early 2024, we launched conditional orders and subsequently saw significant growth in this product over the course of the year. It now has 10 users and set an all time record average daily value in November 2024 of €72m.

Throughout the year, we made enhancements to the existing Auction on Demand product and continued to see high trading volumes in the Market at Close ('MaC'), with a new record MaC ADV of €769m set in June 2024.

An increase to the MTF stock universe now allows clients to trade more than 6,500 stocks and ETFs across 16 European markets, and members are also now able to use OptimX blotter scraping functionality.

Aquis Technologies

Aquis Technologies, where Aquis licenses its leading exchange related technology to a variety of international financial services clients across different asset classes, saw a decline in net revenue over the period by 74.9% (to £1.6m) following a strong 2023, due to increased credit provisions against two technology contracts as well as the non-renewal of a contract with a start-up exchange. In accordance with Aquis' accounting policies, management increased its ECL provisions in respect of two existing technology clients, reflecting a heightened credit risk.

Aquis remains focused on diversifying its technology client mix and there was strong growth in the division's contract pipeline over the period - increasing materially to stand at record levels. The division's client profile continues to strengthen, with more than half of the prospects being national exchanges or central banks. The division signed one new contract during the period, renewed one contract and saw one non-renewal of an existing contract.

The profile and awareness of Aquis Technologies also continues to rise, and the division was awarded Best Matching Engine for Exchanges and Electronic Trading Venues at the 2024 TradingTech Insight Awards (both Europe and US).

Post-period end, Aquis Technologies was pleased to reach the 'design study' stage for a national exchange group, for which it has been participating in an RFP process for provision of exchange technology across multiple markets since early 2024. This stage of the RFP process is exploratory, and involves such activities as identifying scope of work, exploring and testing hardware requirements, IT system integration architecture and software capability.

Aquis Data

Data revenues increased by 33.3% to reach £5.0m (2023: £3.7m), reflecting a full year of charging member data fees along with the addition of five new customers. The Group continues to benefit from increased recognition of the quality and competitive price of Aquis market data, and we expect that it will continue to make a significant contribution.

In addition to the contribution data brings to the Group results, management believe in the medium-term it will increase further in importance when consolidated tapes for the UK and Europe are implemented.

Implementation timetables from 2026 have been announced and it is widely recognised and accepted that introducing consolidated tapes for equities should improve the quality and pricing of market data and lead to a fairer distribution of data fees across the various European trading venues.

Aquis Stock Exchange (AQSE)

The IPO market remained subdued over the period, with low admission numbers on all UK markets. However, we are pleased to have welcomed three new issuers to the Aquis Stock Exchange in 2024, and to see five issuers graduating from Access to Apex after achieving the requisite size and corporate governance requirements.

Many of the improvements we have made over the past three years to aid access and liquidity on the exchange are beginning to bear fruit. £118m was raised by issuers over the year (an increase of 27% on the £93m raised in 2023, with 22 fundraises exceeding £1m and a 39% increase in the total value of further issues - a record year for AQSE since acquisition.

There was also an improvement in trading, with a 21% increase in the value of trading to over £177m.

We continue to be enthused by the opportunity to build a pan-European, technology-driven listing exchange for growth companies and believe we will be well positioned when market conditions start to improve.

Further Investment in Research and Development (R&D)

The Group continued to invest in R&D throughout 2024 in order to maintain and enhance the quality of our technology and its ability to deliver new products and platform enhancements to our clients.

Our proven trading platform has been developed in-house and is based on proprietary technology, which does not rely on third party software suppliers.

I believe this commitment to continued investment in R&D gives us a significant competitive advantage on functionality, price and ability to deliver. The organisation of Aquis' technology department ensures expeditious product development and, together with Aquis' further investment, will allow the Group to react quickly to dynamic market conditions. We intend to continue to work on further developments which will foster future growth.

Resources

During 2024, we continued to invest in personnel resources across a number of departments with headcount across the London and Paris offices increasing by 19% to 88 (FY23: 74). We intend to further strengthen our team, particularly in support of technology development and infrastructure.

The Recommended Offer

On 11 November 2024, the boards of SIX and Aquis were pleased to announce that they had reached agreement on the terms of the Recommended Offer. The Aquis Directors have concluded that the terms of the Recommended Offer provide Aquis shareholders with an attractive opportunity to accelerate and de-risk future value creation, and thus, the Aquis Directors recommended unanimously in favour of the Scheme.

The Scheme, and resolutions related to the Recommended Offer, were approved by the requisite majorities of Aquis shareholders at the Court Meeting and General Meeting held on 20 December 2024.

The Scheme remains subject to the satisfaction (or waiver, where applicable) of certain conditions, including the receipt of certain regulatory approvals and subsequent sanction of the Scheme by the High Court of Justice; full details of the conditions can be found in Part III of the Scheme Document. Presently, Aquis has obtained all of the approvals required to satisfy the antitrust conditions. The remaining conditions, which relate to regulatory approvals, are expected to be satisfied in Q2 2025, and the Scheme remains expected to become effective in Q2 2025 and, in any event, prior to 11 November 2025.

 

Outlook

2024 was an important year for Aquis, and despite difficult conditions I am proud of the achievements of our team across market share, technology innovations, new contracts and strengthening of the primary market.

We remain confident in Aquis' unique proposition and our ability to create and facilitate better markets for a modern economy. We will also continue to promote the Aquis values of transparency, fairness and simplicity, enabling our end customers to get better performance and results.

Our principal aim in the near future is to deliver the completion of the Recommended Offer.

Our highly capable and experienced management team remains focused on serving our clients as we capitalize on the opportunities ahead.

David Stevens

Chief Executive Officer

 

 

Financial Review

2024 saw broadly flat gross revenues, with the company benefitting from the diversified product offerings between divisions. The breakdown of revenues is as follows:

 

2024

£

2023

£

YoY Growth

%

Revenue analysed by division

 

 

 

Markets

11,775,892

10,919,263

7.8%

Technology

5,264,639

7,298,157

-27.9%

Stock Exchange

1,768,077

1,771,284

-0.2%

Market Data

4,963,407

3,722,237

33.3%

 

23,772,015

23,710,941

0.3%

 

The Group generated an Adjusted Profit Before Tax of £1.1m compared to £5.2m in the previous year.

A reduction in Adjusted PBT is explained by increases in Expected Credit Loss provisions against Contract Assets and Trade Receivables balances by £3.7m and £0.6m, respectively. Of these amounts, £3.0m of Contract Asset and £0.6m of Trade Receivable impairments reflected a heightened risk of default for two existing technology customers.

Adjusted Profit Before Tax excludes exceptional costs of £3.3m incurred for the Recommended Offer, and have been included in the Loss Before Tax of (£2.2m) (2023: Profit of £5.2m).

The Loss Before Tax includes amortisation charges to internally generated intangible assets, as well as depreciation and finance charges, which reflect the accounting treatment of leases under IFRS 16 and other tangible fixed assets. The total depreciation and amortisation cost to the Group increased by £0.3m to £1.7m (2023: £1.4m) because of continuing investment in the Group's technological capabilities.

The Group generated an income tax charge of £235k (2023: credit of £8k) which was a result of taxable profits provided in the foreign subsidiary. There was no change in the amount of net deferred tax asset (2023: increase of £191k).

Net assets of the Group as at 31 December 2024 were £25.8m (31 December 2023: £28.4m), largely reflecting cash out flows for exceptional costs and an increase in ECL provisions against Contract Assets and Trade Receivables.

Revenue from licensing technology contracts is subject to a provision under IFRS 9 for Expected Credit Losses. For 2024 the application of IFRS 9 resulted in a net impairment provision charge of £3.7m (2023: £1.0m) recognised in the Income Statement, including an increase in provisions against two existing customers for £3.0m.

Trade receivables balances contained provisions of £0.8m in the year, of which £0.7m related to balances outstanding by the same two technology customers, for which a charge of £0.6m was recognised in the year.

Balance sheet liabilities included provisions of £0.3m recognised in 2024 for disputes with two data vendors over historical fees.

The lease liabilities arising from the Group's office leases are paid over the lease term, and attract a finance expense amounting to £84k for 2024. The associated right of use assets are depreciated on a straight-line basis over the life of the lease, and attract a depreciation charge of £383k for 2024.

The Group's cash and cash equivalents as at 31 December 2024 decreased to £13.7m (2023: £14.8m), including payment of exceptional costs amounting to £3.0m. The continued growth (when exceptional costs are excluded) demonstrates the robust cash generation of continuing business activities in the Group. Over the year the Group purchased £1.5m of treasury shares used to service employee share schemes.

Regulatory capital

The Group is required to maintain sufficient capital to meet the regulatory obligations for all entities. These are calculated and updated annually. At 31 December 2024, the Company ICARA requirement (based on the 2023 published financial Annual Report and Accounts) amounted to £6.2m (2023 £5.2m) and AQSE's FRR amounted to £2.5m (2023 £2.1m). The individual entities of the Group meet the respective FCA and ACPR capital adequacy requirements with plenty of headroom for further investment in business operations.

Future development of the business

In order to support its long-term vision and in order to strategically position for continued growth, Aquis has invested significantly in its business differentiators, R&D in the technology platform, brand and personnel resources. The Group is cognisant of the importance of such investments to maintain innovation and strong quality delivery and the Board considers that its investments have contributed to the Group's ability to gain new clients, broaden its customer base and increase revenue.

The Group recognises the importance of continuing to enhance productivity, and the commitment to future investment, both technically and in terms of resource training and development. The Group has established both short and long-term incentive plans based on performance for all employees, which are set out in more detail in the Report of the Nomination and Remuneration Committee and aligns the employees' interests with the long-term strategic objectives of the Group.

Aquis Stock Exchange

During 2024, the Group has continued to invest in AQSE, building market presence and brand whilst also benefitting from synergies across the Group's exchange memberships, data offering and use of technology.

Alternative Performance Measures (APMs)

This report contains certain financial measures (APMs) that are not defined or recognised under IFRS but have been presented to provide readers with a complete set of financial information which would allow a user of this Annual Report and Accounts to better understand and compare the financial performance of the Group.

Net Revenue

Net Revenue is the revenue that is generated and offset against the Expected Credit Loss (ECL) movement of contract asset balances (note that this does not include the ECL movement on trade receivable balances).

Each contract asset balance is assessed against the expected ability of a customer to satisfy open balances in future periods. On inception of new Technology licences a contract asset is recognised, alongside a day-1 ECL provision. In this scenario, the Net Revenue from this customer would be the Licence Fee (see Note 10 for details of performance obligations for technology contracts) offset against ECL provision (see Note 11 for impairment analysis).

For extant technology contracts, as the contract asset balance is reduced by cash receipts from the customer, the associated ECL provision is reduced; in this scenario the release of the ECL balance is shown as Net Revenue.

The excerpt below demonstrates the effect of Net Revenues from Aquis Technologies (see Note 6for a full analysis of segment performance).

 

 

Group and Company

 

2024

£

2023

£

Revenue from technology customers

5,264,639

7,298,157

Net ECL Charge

(3,685,326)

(1,016,223)

Net Revenue

1,579,313

6,281,934

 

Adjusted EBITDA (before exceptionals) and Adjusted Profit Before Tax

Adjusted EBITDA is the earnings before interest, taxation, depreciation, and amortisation excluding material non-recurring "Recommended Offer" costs. Similarly, Adjusted Profit Before Tax is the profit before tax excluding material non-recurring Offer costs.

The Directors use these metrics to assess Group performance to show the underlying economic performance year-on-year. Offer costs are treated as exceptional items as they are neither related to the ongoing activities of the Group, nor are they repeatable expenditures.

Recommended Offer costs include staff costs, in addition to the various legal and professional fees paid for the necessary professional services. In 2024, the Adjusted EBITDA of the Group was £2.2m (2023: £6.3m) and the Adjusted PBT was £1.1m (2023: £5.2m).

The following reconciliation demonstrates the impact of excluding Exceptional Recommended Offer costs from Adjusted EBITDA and Adjusted PBT.

 

Adjusted EBITDA

Group

2024

£

2023

£

EBITDA

(1,182,818)

6,270,252

Add back Exceptional Recommended Offer costs

3,343,863

-

Adjusted EBITDA

2,161,045

6,270,252

 

Adjusted PBT

Group

2024

£

2023

£

Loss before tax

(2,226,649)

5,194,887

Add back Exceptional Recommended Offer costs

3,343,863

-

Adjusted profit before tax

1,117,214

5,194,887

 

Consolidated statement of comprehensive income

For the year ended 31 December 2024

Group

Company

2024

2023

2024

2023

Notes

£

£

£

£

Profit and loss

Revenue

10

23,772,015

23,710,941

11,680,818

13,147,339

Impairment charge on contract assets

11

(3,685,326)

(1,016,223)

(3,685,326)

(1,016,223)

Impairment charge on trade and other receivables

11

(702,437)

(79,395)

(601,598)

(59,608)

Other (losses) / gains

12

(138,437)

51,407

(138,437)

51,407

Operating expenses

12

(17,084,770)

(16,396,478)

(6,022,669)

(6,874,123)

Exceptional Recommended Offer costs

13

(3,343,863)

-

(3,319,520)

-

Earnings before interest, taxation, depreciation and amortisation

(1,182,818)

6,270,252

(2,086,732)

5,248,792

Depreciation and amortisation

12

(1,660,998)

(1,372,565)

(1,590,993)

(1,299,276)

Finance expense

12, 28

(84,256)

(103,249)

(71,705)

(88,571)

Finance income

12

701,423

400,449

300,861

127,447

(Loss) / profit before taxation

(2,226,649)

5,194,887

(3,448,569)

3,988,392

Income tax (charge)/credit

16

(235,291)

7,789

-

49,837

(Loss) / profit for the year

(2,461,940)

5,202,676

(3,448,569)

4,038,229

Other comprehensive income

Items that may be subsequently reclassified to profit or loss:

Foreign exchange differences on translation of foreign operations

(212,740)

(120,961)

-

-

Other comprehensive income for the year

(212,740)

(120,961)

-

-

Total comprehensive (loss) / income for the year

(2,674,680)

5,081,715

(3,448,569)

4,038,229

Earnings per share (pence) Basic

Ordinary shares

17

(9)

19

(13)

15

Diluted

Ordinary shares

17

(9)

19

(12)

14

Consolidated statement of financial position

As at 31 December 2024

Group

Company

2024

2023

2024

2023

Notes

£

£

£

£

Non-current assets

Goodwill

18

83,481

83,481

-

-

Intangible assets

18

2,417,524

1,501,885

2,417,524

1,501,885

Property, plant and equipment

19

3,290,675

3,818,841

2,892,632

3,350,793

Investment in subsidiaries

20

-

-

6,884,202

6,884,202

Investments

21

1,176,021

591,945

1,176,021

591,945

Investment in trusts

22

-

-

5,702,768

4,389,445

Deferred tax asset

15

1,785,331

1,785,331

1,506,022

1,506,022

Trade and other receivables

23

3,169,367

5,811,089

3,158,605

5,795,918

11,922,399

13,592,572

23,737,774

24,020,210

Current assets

Trade and other receivables

23

7,653,949

6,894,936

8,422,762

6,736,943

Derivative financial instruments

5

-

51,407

-

51,407

Cash and cash equivalents

25

13,699,076

14,765,910

5,745,324

6,356,259

Total assets

33,275,424

35,304,825

37,905,860

37,164,819

Current liabilities

Provisions

26

343,784

-

343,784

-

Derivative financial instruments

5

3,219

-

3,219

-

Trade and other payables

27

5,083,208

4,471,470

6,454,845

3,665,932

Net current assets

15,922,814

17,240,783

7,366,238

9,478,677

Non-current liabilities

Lease liabilities

28

2,037,577

2,457,105

1,734,788

2,100,483

2,037,577

2,457,105

1,734,788

2,100,483

Total liabilities

7,467,788

6,928,575

8,536,636

5,766,415

Net total assets

25,807,636

28,376,250

29,369,224

31,398,404

Equity

Called up share capital

29

2,760,253

2,751,678

2,760,253

2,751,678

Share premium account

33

12,098,734

11,809,757

12,098,734

11,809,757

Other reserves

34

3,863,426

2,741,589

3,863,426

2,741,589

Treasury Shares

30

(5,702,768)

(4,389,445)

-

-

Retained earnings

13,057,567

15,519,507

10,646,811

14,095,380

Foreign currency translation reserve

(269,576)

(56,836)

-

-

Total equity

25,807,636

28,376,250

29,369,224

31,398,404

David Stevens

CEO

Richard Fisher

CFO

Statement of changes in equity

For the year ended 31 December 2024

Group

Notes

Share Capital

Share Premium

Share Based Payment Reserve

Retained Earnings

Treasury Shares

Foreign Currency Translation

Reserve

Total

Balance at 1 January 2023

2,750,945

11,785,045

1,813,119

10,316,831

(3,350,325)

64,125

23,379,740

Profit for the year

-

-

-

5,202,676

-

5,202,676

Foreign exchange differences on translation of foreign operations

-

-

-

-

-

(120,961)

(120,961)

Total comprehensive income for the year

-

-

-

5,202,676

-

(120,961)

5,081,715

Issue of new shares

29, 33

733

24,712

-

-

-

-

25,445

Movement in share based payment reserve

34

-

-

928,470

-

-

-

928,470

Movement in treasury shares

30

-

-

-

-

(1,039,120)

-

(1,039,120)

Balance at 31 December 2023

2,751,678

11,809,757

2,741,589

15,519,507

(4,389,445)

(56,836)

28,376,250

Balance at 1 January 2024

 

2,751,678

11,809,757

2,741,589

15,519,507

(4,389,445)

(56,836)

28,376,250

Loss for the year

-

-

-

(2,461,940)

-

-

(2,461,940)

Foreign exchange differences on translation of foreign operations

-

-

-

-

-

(212,740)

(212,740)

Total comprehensive loss for the year

-

-

-

(2,461,940)

-

(212,740)

(2,674,680)

Issue of new shares

29, 33

8,575

288,977

-

-

-

-

297,552

Movement in share based payment reserve

34

-

-

1,121,837

-

-

-

1,121,837

Movement in treasury shares

30

-

-

-

-

(1,313,323)

-

(1,313,323)

Balance at 31 December 2024

2,760,253

12,098,734

3,863,426

13,057,567

(5,702,768)

(269,576)

25,807,636

 

For the year ended 31 December 2024

Company

Notes

Share capital

Share premium

Share Based

Payment Reserve

Retained Earnings

Total

Balance at 1 January 2023

2,750,945

11,785,045

1,813,119

10,057,151

26,406,260

Profit and total comprehensive income for the year

-

-

-

4,038,229

4,038,229

Issue of new shares

29,33

733

24,712

-

-

25,445

Movement in share based payment reserve

34

-

-

928,470

-

928,470

Balance at 31 December 2023

2,751,678

11,809,757

2,741,589

14,095,380

31,398,404

Balance at 1 January 2024

2,751,678

11,809,757

2,741,589

14,095,380

31,398,404

Loss and total comprehensive loss for the year

-

-

-

(3,448,569)

(3,448,569)

Issue of new shares

29, 33

8,575

288,977

-

-

297,552

Movement in share based payment reserve

34

-

-

1,121,837

-

1,121,837

Balance at 31 December 2024

2,760,253

12,098,734

3,863,426

10,646,811

29,369,224

Statement of cash flows

For the year ended 31 December 2024

Group

Company

2024

2023

2024

2023

Notes

£

£

£

£

Net cash flows from operating activities

31

2,525,063

4,103,719

3,133,650

4,340,136

Investing activities

Recognition of intangible assets

18

(1,744,353)

(1,081,918)

(1,744,353)

(1,081,918)

Purchase of property, plant and equipment

19

(387,929)

(411,316)

(387,929)

(409,731)

Recovery of deposit on leases

28

442,254

-

437,400

-

Investment acquisitions

21

(584,076)

(591,945)

(584,076)

(591,945)

Interest received

651,009

384,712

208,701

112,154

Loans made to EBTs

-

-

(1,534,480)

(1,196,309)

Net cash used in investing activities

(1,623,095)

(1,700,467)

(3,604,737)

(3,167,749)

Financing activities

Issue of new shares

29, 33

297,552

25,445

297,552

25,445

Principal portion of lease liability

5, 28

(519,134)

(516,482)

(437,400)

(437,400)

Purchase of treasury shares

(1,534,480)

(1,196,309)

-

-

Net cash used in financing activities

(1,756,062)

(1,687,346)

(139,848)

(411,955)

Net (decrease)/increase in cash and cash equivalents

(854,094)

715,906

(610,935)

760,432

Cash and cash equivalents at the beginning of the year

14,765,910

14,170,965

6,356,259

5,595,827

Effect of exchange rate changes on cash and cash equivalents

(212,740)

(120,961)

-

-

Cash and cash equivalents at the end of the year

13,699,076

14,765,910

5,745,324

6,356,259

Notes to the Financial Statements

1. Significant Changes in The Reporting Period

The following events and transactions had an impact on the financial position and performance of the Group and/or Company during the period:

Following the Offer to acquire Aquis by SIX Group, the Group has incurred material expenditure on the deal. These costs were presented as exceptional items in the Financial Statements, resulting in the use of alternative performance measures. Details of these costs have been outlined in Note 13.

 

2. Basis of preparation and accounting policies

Company information

Aquis Exchange PLC is a public limited company which is incorporated and domiciled in the United Kingdom. Its registered office is located at 63 Queen Victoria Street, London, EC4N 4UA. The Company Number is 07909192.

Accounting convention

The Group's consolidated and the Company's financial statements are prepared in accordance with UK- adopted international accounting standards and the Companies Act 2006 requirements.

The financial statements have been prepared on the historical cost basis as modified by the revaluation of financial instruments carried at fair value through profit and loss.

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Going concern

At the time of approving the financial statements, the Directors have a reasonable expectation that the Group has adequate resources to continue in operational existence for the foreseeable future and thus continue to adopt the going concern basis of accounting in preparing the financial statements.

In the year there has been material expenditure on deal related costs, see note 13, related to the offer to acquire Aquis by SIX Group. While the quantum of these costs has been material they have been treated as exceptional because they will not repeat in subsequent years. The underlying activities of the group remain profitable in 2024. The Group, at and after the balance sheet date, maintains sufficient liquidity to meet its regulatory commitments in the UK and France. Therefore, the directors are confident there is no risk to the going concern of the Group and Company.

 

Taking the above into account, the principal risks discussed in the Strategic Report section of the Annual Report, the financial risks and mitigating actions taken by management (see Note 5), and the Group's current financial position, the Directors do not foresee any material uncertainty in the Group's ability to continue as a going concern over a period of at least 12 months from the date of approval of these financial statements and hence the financial statements have been prepared on a going concern basis.

Consolidation

In preparing these financial statements, the group has applied the consolidation principles in IFRS 10, Consolidated Financial Statements. This requires the Group to consolidate subsidiary entities it controls. Control is determined based on the ability to direct the activities of the entity that significantly affect its returns.

The Group assesses control on a continuing basis and includes entities it controls as of the end of the reporting period.

The financial statements of the consolidated entities are prepared using consistent accounting policies and are presented as if they were a single economic entity. Intercompany transactions, balances, and unrealised gains and losses on transactions between consolidated entities are eliminated in full.

The Group consolidated financial statements also include treasury shares and cash held by two separate trusts ("the Trusts") that administers the Company's employee share incentive plan and also hold shares purchased by the Group in preparation for future settlement of employee share awards made to date. The Trusts have been consolidated based on the IFRS 10 criteria for control over the Trust being met:

The Trusts were established to (i) facilitate the acquisition and holding of shares under the Aquis Exchange PLC Share Incentive Plan and (ii) facilitate the acquisition and holding of shares under all other Aquis Exchange share plans.

The activities of the Trusts are limited by the agreements in place; and

The Trusts do not have any assets outside of the partnership share money received and the shares purchased. The use of any shares or cash that remain in the Trust funds once the trustee no longer holds any shares relating to the SIP, RSP or PPO, is directed by the Company. The Trust itself has no rights to any dividends.

Accounting Policies

Revenue

Revenue comprises amounts derived from the provision of services which fall within the Company's ordinary activities. It represents amounts receivable for subscription fees, the licensing of software, the provision of data to third-party vendors, and fees relating to listings on the Aquis Stock Exchange ("AQSE"), all of which are net of value added tax. Revenue is recognised once the performance obligations for each activity have been satisfied.

All the revenue streams are generated by contracts with customers and revenue is therefore recognised in accordance with IFRS 15.

Revenue from exchange subscription-based services is recognised over time when the services are rendered.

Revenue from licensing contracts is assessed for each contract and split into five Performance Obligations (see Note 10 for further details on 'POs' and Note 4 for Judgements and estimates):

Project Implementation / Design fees (PO1) recognised over time as the obligations are met;

Licencing fees (PO2) recognised at a point in time when the licence is transferred to the customer;

Maintenance fees (PO3) recognised over time as the obligations are met;

Live services fees (PO4) recognised over time as the obligations are met;

Hosting fees (PO5) recognised over time as the obligations are met.

Revenue from the provision of data to third-party vendors is comprised of the annual fees paid by the redistributors, member firms and multi-media firms for access to real time and/or end of day data and is recognised over time. An additional monthly fee is received based on the number of users the vendors provide the data to each month. This additional monthly fee is variable and is based on usage for the prior month. The fee is charged in arrears and is recognised in the month it is incurred.

Revenue from AQSE issuer fees is comprised of initial application and admission fees, annual fees, and further issue fees, these are all recognised over time under IFRS 15 except further issue fees which are recognised at a point in time.

Application and admission fees are charged upfront to prospective companies admitted to AQSE markets. These are recognised monthly over the average expected life of company admission periods (further details about this estimate are set out in the following section).

Annual fees are paid upfront annually by companies with securities listed on AQSE and are recognised over the year.

Further issue fees are incurred by existing issuers who have already contributed an application and admission fee and are recognised at a point in time on the date the new security is available for trade on AQSE.

Estimated listing period for Aquis Stock Exchange securities

In recognising application and admission fees, the Company determines the expected length of time each new security will be listed on AQSE. The estimate is based on historical analysis of listing durations in respect of the companies listed on AQSE. The length of time a security remains listed incorporates significant uncertainty as it is based on factors outside the control of the Company and which are inherently difficult to predict.

Based on the available information and incorporating management's predictions, it is currently estimated that an average security will remain listed for a period of 9 years. Application and admission fees are recognised monthly over a period of time.

It is estimated that a one year increase/ decrease in the deferral period would cause an £10k decrease / £8k increase in annual revenue released respectively. The estimated listing periods will be reassessed at each reporting date to ensure they reflect the best estimates of the Group.

 

Intangible assets other than goodwill

Internally generated intangible assets

Internally developed intangible assets arising from the capitalisation of Development expenditures, product analysis, quality assurance, and website development costs are recognised in the financial statements when all of the following criteria are met:

The technical feasibility of completing the intangible asset so that it will be available for use or sale is established;

There is an intention to complete the intangible asset and use or sell it;

The Group has the ability to use or sell the intangible asset;

The existence of a market for the output of the intangible asset or the intangible asset itself or, if it is to be used internally, the usefulness of the intangible asset can be demonstrated;

Adequate technical, financial and other resources are available to complete the development and to use or sell the intangible asset; and

The Group has the ability to measure reliably the expenditure attributable to the intangible asset during its development.

Where the above criteria are not met, costs incurred in research and development are recognised in the Statement of Comprehensive Income as incurred. Research costs are expensed as incurred.

Amortisation is recognised in order to write off the cost or valuation of the assets, less their residual values over their useful lives. The development of trading platforms has been amortised over 3 years on a straight-line basis reflecting management's estimate of the useful life of the technology, the rationale of which is discussed in Note 4.

Other intangibles

Website technology and communication licences represent externally acquired intangible assets and are recognised in the financial statements as the Group receives the right to control and use the product over a period of time. Website technology represents external development costs to design the Group's website. Communication licences relate to licences that transfer the right to obtain a benefit from intellectual property. Amortisation on these assets is recognised over 3 years on a straight-line basis which represents the estimated useful life of both types of asset.

The price of and acquisition costs incurred when obtaining customer lists and IP Addresses is capitalised in line with IAS 38. Management expects that future economic benefits are attributable to the entity over an indefinite term for these assets. Therefore, the useful economic life is considered indefinite and no annual amortisation is recognised. These assets are subsequently recognised as cost less impairment, and at each balance sheet date Management conducts and impairment review which is at a minimum annually.

 

Business Combination

Business combinations are accounted for using the acquisition method. The cost of an acquisition is measured as the aggregate of the consideration transferred, which is measured at fair value.

Acquisition-related costs are expensed as incurred and recognised as non-underlying transaction costs in the income statement.

Goodwill

The acquisition of AQSE gave rise to goodwill in the consolidated financial statements. Goodwill is initially measured at cost, being the excess of the aggregate of the consideration transferred over the net identifiable assets acquired and liabilities assumed. Goodwill is assessed for impairment annually, with any impairment charge recognised in the Statement of Comprehensive Income. Note 18 provides further detail on the impairment assessment for goodwill as at 31 December 2024.

Property, plant and equipment (excluding right-of-use assets)

All property, plant and equipment are stated at historical cost less depreciation or impairment. Historical cost includes expenditure that is directly attributable to the acquisition of the items.

Subsequent expenditure is included in the asset's carrying amount or is recognised as a separate asset, as appropriate, only when it is probable that future economic benefits associated with the item will flow to the Group and the cost of the item can be measured reliably. All other repair and maintenance costs are charged to the income statement during the financial period in which they are incurred.

Depreciation is recognised so as to write off the cost or valuation of assets, less their residual values, over their useful lives on the following basis:

Fixtures, fittings and equipment: 5 years straight line.

Computer equipment: 3 - 7 years straight line.

Impairment of tangible and intangible assets

At each reporting end date, the Group reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the Group estimates the recoverable amount of the cash-generating unit to which the asset belongs.

The recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.

 

If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash- generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

Cash and cash equivalents

Cash and cash equivalents include cash at bank.

The Group and Company as regulated bodies are required to maintain liquid cash assets as part of their prudential reporting responsibilities to external regulators. During the financial year ended 31 December 2024 the Group was required to maintain £7,970k of available cash assets as part of its liquidity requirements (Company £4,709k). Further details of the Group's risk management approach to regulatory capital commitments are included in Note 5.

Financial assets

Trade and other receivables

Trade receivables are amounts due from customers for services performed in the ordinary course of business. Other receivables are defined as amounts due that are outside the ordinary course of business. If collection is expected in one year or less (or in the normal operating cycle of the business if longer) they are classified as current assets. Otherwise they are presented as non-current assets.

Contract assets

Contract assets are recognised for licensing fees recognised at inception of a licensing contract but not yet billed under IFRS 15. Contract assets are initially measured at fair value and subsequently measured at amortised cost and are stated net of any expected credit loss provision ("ECL") recognised in accordance with IFRS 9, as detailed in Note 11. Contract assets are presented on the Statement of Financial Position as trade receivables. The right to consideration becomes unconditional once the customer has been billed.

Investments

Investments in equity instruments at fair value through other comprehensive income (FVTOCI) are initially measured at fair value plus transaction costs. Subsequently, they are measured at fair value with gains and losses arising from changes in fair value recognised in other comprehensive income and accumulated in the revaluation reserve. The cumulative gain or loss is not reclassified to profit or

loss on disposal of the equity investments, instead, it is transferred to retained earnings. Dividends on these investments in equity instruments are recognised in profit or loss as other income when the Group's right to receive payments is established, unless the dividends clearly represent a recovery of part of the cost of the investment.

 

Rent deposit asset

Under IFRS 16 a rent deposit is accounted for as a financial asset if the collateral provided to the lessor is not a payment relating to the right to use the underlying assets and hence is not a lease payment as defined.

Further disclosures are provided in Note 28.

Impairment of financial assets

The Group has considered the impact of the application of an expected credit loss model when calculating impairment losses on current and non- current contract assets and other financial assets at amortised cost (presented within trade and other receivables). In applying IFRS 9 the Group must consider the probability of a default occurring over the contractual life of its trade receivables and contract asset balances on initial recognition of those assets.

Note 11 details the Group's credit risk assessment procedures.

Financial liabilities

After initial recognition all financial liabilities are subsequently measured at amortised cost using the effective interest method. The effective interest method is a method of calculating the amortised cost of a financial liability and of allocating interest expense over the relevant period. The effective interest rate is the rate that exactly discounts estimated future cash payments (including all fees and points paid or received that form an integral part of the effective interest rate, transaction costs and other premiums or discounts) through the expected life of the financial liability, or (where appropriate) a shorter period, to the amortised cost of a financial liability. In 2024 the Group did not hold any financial liabilities beyond Trade and other payables and the lease liabilities recognised under IFRS 16 as described in the "Leases" sub-section below.

Trade and other payables

Trade payables are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if payment is due within one year or less (or in the normal operating cycle of the business if longer). If not, they are presented as non-current liabilities. Trade and other payables are not interest bearing and are initially recognised at fair value.

Financial assets at fair value through profit or loss

Financial assets at fair value through profit or loss are carried at fair value with net changes in fair value reflected in the income statement. This category includes derivative instruments.

Equity instruments

Ordinary shares are classified as equity. Incremental costs directly attributable to the issue of new ordinary shares or options are charged against the share premium account.

 

Earnings per share

The earnings per share (EPS) calculations are based on basic earnings per ordinary share as well as diluted earnings per ordinary share. The basic EPS is calculated by dividing the profit after tax of the Group by the weighted average number of ordinary shares that were in issue during the year. The diluted EPS takes into account the dilution effects which would arise on conversion of all outstanding share options and share awards under the Enterprise Management Incentive (EMI) scheme.

Taxation

The tax expense/(credit) represents the sum of the tax currently payable/(repayable) and movements in deferred tax balances.

A R&D tax credit is claimed annually from HMRC based on the employee costs involved in developing Aquis' systems and technology. R&D tax credits are offset against taxable profits or, when the company is in a tax loss position claimed as a cash credit.

Current tax

The current income tax charge/(credit) is calculated on the basis of the tax laws enacted or substantively enacted at the balance sheet date in the country where the company operates and generates taxable income. Management periodically evaluates positions taken in tax returns with respect to situations in which applicable tax regulation is subject to interpretation. It establishes provisions where appropriate on the basis of amounts expected to be paid to the tax authorities.

Deferred tax

Deferred income tax is recognised, using the liability method, on temporary differences arising between the tax bases of assets and liabilities and their carrying amounts in the financial statements. Deferred income tax is determined using tax rates (and laws) that have been enacted or substantially enacted by the balance sheet date and are expected to apply when the related deferred income tax asset is realised, or the deferred income tax liability is settled.

Deferred income tax assets are recognised only to the extent that it is probable that future measurable taxable profit will be available against which the temporary differences can be utilised.

Deferred income tax assets and liabilities (Note 15) are offset when there is a legally enforceable right to offset current tax assets against current tax liabilities and when the deferred income taxes assets and liabilities relate to income taxes levied by the same taxation authority on either the same taxable entity or different taxable entities where there is an intention to settle the balances on a net basis

 

Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of group developed trading platforms.

The cost of any unused holiday entitlement is recognised in the period in which the employee's services are received.

Termination benefits are recognised as an expense when the Group is demonstrably committed to terminate the employment of an employee or to provide termination benefits, as set out within IAS 19.

Retirement benefits

Pension obligations

The Group has no further payment obligations once the contributions have been paid. The contributions are recognised as an employee benefit expense when they are due. Prepaid contributions are recognised as an asset to the extent that a cash refund or a reduction in the future payments is available.

Share-based payments

EMI Options

Equity-settled share-based payments are measured at fair value at the date of grant. The fair value determined at the grant date is expensed on a straight-line basis over the vesting period, based on the estimate of shares that will eventually vest. A corresponding adjustment is made to equity.

When the terms and conditions of equity-settled share- based payments at the time they were granted are subsequently modified, the fair value of the share- based payment under the original terms and conditions and under the modified terms and conditions are both determined at the date of the modification.

Any excess of the modified fair value over the original fair value is recognised over the remaining vesting period in addition to the grant date fair value of the original share-based payment. The share-based payment expense is adjusted if the modified fair value is less than the original fair value. Cancellations or settlements (including those resulting from employee redundancies) are treated as an acceleration of vesting and the amount that would have been recognised over the remaining vesting period is recognised immediately.

Employee share incentive plan

Shares purchased under the share incentive plan are recognised as share-based payments under IFRS 2. Partnership shares are purchased by employees and matching shares are those purchased by Aquis at a ratio of 2:1. The shares are held in a trust ("the Trust"), with matching shares required to be held for three years before being transferred to the employee. The fair value of matching shares are recognised in the share-based payment reserve.

 

Partnership shares vest immediately while matching shares will vest over the three-year holding period. The market value of shares when they are purchased is assumed to approximate the fair value of the shares.

The cash transferred to the Trust is recognised as an investment in the Company's accounts. In line with IFRS 10 guidance, the Trust is consolidated in the Group accounts with the fair value of the shares held in the trust recognised as a debit entry within equity.

Restricted share plan

The Restricted share plan is a share based scheme awarded to staff and has a vesting period of three years after grant subject to continued employment. Similar to share-based payments they are measured at fair value determined at the grant date. The fair value is expensed on a straight-line basis over the vesting period, with the corresponding adjustment being made to reserves.

Company Share Option Plan

The company share option plan is a share based scheme awarded to staff and has a vesting period of three years subject to continued employment. Similar to share-based payments they are measured at fair value determined at the grant date. The fair value is expensed on a straight-line basis over the vesting period, with the corresponding adjustment being made to reserves.

Premium Priced Options Plan

The PPO scheme is an option based share scheme and has a vesting period of three years after the grant date subject to continued employment. Similar to share-based payments they are measured at fair value determined at the grant date. The fair value is expensed on a straight-line basis over the vesting period, with the corresponding adjustment being made to reserves.

Leases - as a lessee

The Group assesses whether a contract is or contains a lease at inception of the contract. The Group recognises a right of use asset and a corresponding lease liability with respect to all lease arrangements in which it is the lessee, except for short-term leases (defined as leases with a lease term of 12 months or less) and leases of low value assets (such as tablets and personal computers, small items of office furniture and telephones). For these leases, the Group recognises the lease payments as an operating expense on a straight-line basis over the term of the lease unless another systematic basis is more representative of the time pattern in which economic benefits from the leased assets are consumed.

 

The lease liability is initially measured at the present value of the lease payments that are not paid at the commencement date, discounted by using the rate implicit in the lease. Lease payments included in the measurement of the lease liability comprise:

Fixed lease payments (including in-substance fixed payments), less any lease incentives receivable;

Variable lease payments that depend on an index or rate, initially measured using the index or rate at the commencement date;

The amount expected to be payable by the lessee under residual value guarantees;

The exercise price of purchase options, if the lessee is reasonably certain to exercise the options; and

Payments of penalties for terminating the lease, if the lease term reflects the exercise of an option to terminate the lease.

The lease liability is presented as a separate line in the consolidated statement of financial position and is subsequently measured by increasing the carrying amount to reflect interest on the lease liability (using the effective interest method) and by reducing the carrying amount to reflect the lease payments made. The Group remeasures the lease liability (and makes a corresponding adjustment to the related right-of-use asset) whenever:

The lease term has changed or there is a significant event or change in circumstances resulting in a change in the assessment of exercise of a purchase option, in which case the lease liability is remeasured by discounting the revised lease payments using a revised discount rate.

The lease payments change due to changes in an index or rate or a change in expected payment under a guaranteed residual value, in which cases the lease liability is remeasured by discounting the revised lease payments using an unchanged discount rate (unless the lease payments change is due to a change in a floating interest rate, in which case a revised discount rate is used).

A lease contract is modified and the lease modification is not accounted for as a separate lease, in which case the lease liability is remeasured based on the lease term of the modified lease by discounting the revised lease payments using a revised discount rate at the effective date of the modification.

The right-of-use assets comprise the initial measurement of the corresponding lease liability, lease payments made at or before the commencement day, less any lease incentives received and any initial direct costs. They are subsequently measured at cost less accumulated depreciation and impairment losses. The right-of-use assets are included in property, plant and equipment in the consolidated statement of financial position and are depreciated over the term of the lease. The Group applies IAS 36 to determine whether a right-of-use asset is impaired and accounts for any identified impairment loss as described in the 'Impairment of tangible and intangible assets' policy. Variable rents that do not depend on an index or rate are not included in the measurement of the lease liability and the right-of-use asset.

Foreign exchange

Functional and presentation currency

Items included in the financial statements of the Group are measured using the currency of the primary economic environment in which the entity operates. The financial statements are presented in UK Pound Sterling (£), which is the Group's functional and presentational currency.

Transactions and balances

Foreign currency transactions are translated into the functional currency using the exchange rates prevailing at the dates of the transactions. Foreign exchange gains and losses resulting from the settlement of such transactions and from the translation of monetary assets and liabilities denominated in foreign currencies at year end exchange rates are recognised in profit or loss.

All foreign exchange gains and losses recognised in the income statement are presented net within 'operating expenses'. For the purpose of presenting consolidated financial statements, the assets and liabilities of the Group's foreign operations are translated at exchange rates prevailing on the reporting date. Income and expense items are translated at the average exchange rates for the period, unless exchange rates fluctuate significantly during that period, in which case the exchange rates at the date of transactions are used. Exchange differences arising, if any, are recognised in other comprehensive income and accumulated in a foreign exchange translation reserve.

On disposal of a foreign operation, exchange differences previously recognised in other comprehensive income are reclassified to the income statement.

Foreign currency contracts used to manage foreign currency risk are accounted for as derivatives as described above under "Financial instruments at fair value through profit or loss".

Provisions

Provisions are recognised when the company has a present legal or constructive obligation arising as a result of a past event, it is probable that an outflow of economic benefits will be required to settle the obligation and a reliable estimate can be made. All provisions are expected to be settled within a year and thus the present value of amounts is materially consistent with the undiscounted amount of future expected cash outflows.

Classification of costs as exceptional

The classification of certain costs as exceptional (see note 13) has a significant impact on the calculation of certain alternative performance measures. The classification of such costs as exceptional was determined because they were not incurred in the normal course of business. Such costs are not repeatable and their exclusion from the underlying business performance was deemed necessary to avoid distortion in the underlying performance of the Group.

Valuation of derivatives

The company uses foreign currency forwards to manage its exposure to exchange rate fluctuations. Although in the current period the reported value is immaterial, there is potential for changes based on large currency or relative interest rate shifts. As such, they are a source of estimation uncertainty. Note 24 provides additional information on the fair value of derivatives.

 

3. Adoption of new and revised standards and changes in accounting policies

New IFRS Standards that are effective for the current year

The following amended standards are effective as of 2024. These have not impacted the current year financial statements.

 

Amendments to IAS 1 Presentation of Financial Statements

Classification of Liabilities as Current or Non-current (Issued January 2020) and Non-current Liabilities with Covenants (Issued October 2022)

Amendments to IFRS 16 Leases

Lease Liability in a Sale and Leaseback (Issued September 2022)

Amendments to IAS 7 Statement of Cash Flows and IFRS 7 and IFRS 9 Financial Instruments

Supplier Finance Arrangements (Issued May 2023)

Standards which are in issue but not yet effective

At the date of authorisation of these financial statements, the following Standards and Interpretations, which have not yet been applied in these financial statements, were in issue. The Directors do not expect that the adoption of the Standards listed below will have any impact on the financial statements of the Group in future periods:

 

Amendments to IAS 21

The Effects of Changes in Foreign Exchange Rates: Lack of Exchangeability (Issued August 2023) - effective 1 January 2025

 

Amendments to IFRS 9 and IFRS 7

Amendments to the Classification and Measurement of Financial Instruments (Issued May 2024) - effective 1 January 2026

IFRS 18

Presentation and disclosure in Financial Statements effective 1 January 2027

IFRS 19

Subsidiaries without Public Accountability: Disclosures effective 1 January 2027

4. Critical accounting estimates and judgements

In applying the Group's accounting policies, which are described in Note 2, the Directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. Management has shown these matters as judgements where they relate to a significant policy and the judgement has a material impact on the reported balance. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods.

Critical judgements

The following are the critical judgements, apart from those involving estimations (which are presented separately below), that the Directors have madein the process of applying the Group's accounting policies and that have the most significant effect on the amounts recognised in financial statements.

 

Judgements in relation to performance obligations

In making their judgement, the Directors considered the detailed criteria for the recognition of revenue set out in IFRS 15, and in particular, whether revenue is recognised at a point in time or over time. Following an assessment of the technology licensing contract portfolio, and the obligations that Aquis has under each contract, the Directors are satisfied that obligations contained therein be split into the following performance obligations, and that the revenue from each licensing contract should be assessed individually. The identified performance obligations and the timing of revenue recognition on delivering the licence contracts as follows:

Implementation/ project fees: these are upfront, non-refundable fees that a customer pays in order to obtain the user agreement. Even if the user acceptance certificate is never issued, the implementation fee cannot be reclaimed and so the revenue is guaranteed and can be recognised from the time of invoice as Aquis becomes unconditionally entitled to payment but in practice recognition will often be deferred until the work is completed.

Licensing fees: The customer is liable to pay the monthly licensing fee from the date of signing the user acceptance agreement (contract inception date). At this point in time Aquis has fulfilled its promise to deliver the licence (i.e. the system has been deployed in the client's production environment) and this performance obligation is fulfilled. Management uses judgement when assessing the recoverability of the licencing fees, and recognises them only when their collection is assumed to be highly probable. This assessment takes into consideration the current status of the client's business, including whether the exchange system is active with products/ securities added and members trading on it. The licensing fees are recognised at a point in time, which occurs after the contract is signed and once Aquis is satisfied that receiving the licencing fees is highly probable.

Maintenance fees: fees to maintain the system are recognised over the course of the licensing contract as Aquis fulfils its performance obligation to maintain the system. Management have estimated a fixed annual amount per contract, which reflects the time spent supporting the client's platform and upgrading the software in accordance with the contractual terms.

Live services: fees charged to support infrastructure, operations, and first-line market surveillance as part of running regulatory grade exchanges. These services are recognised over time when Aquis provides the service.

Hosting: these fees are charged for the use of Aquis' hardware on a monthly basis. These services are recognised over time as the customer requires.

Changes in identification of performance obligations could impact the timing of revenue recognition for licensing contract assets and is thus a critical accounting judgement.

 

Capitalisation of internally generated intangible assets resulting from Research and Development

Internally generated intangible assets are capitalised when, in management's judgement, the criteria for capitalisation under IAS 38 (listed in Note 2) have been met. The direct costs incurred in the research and development of Aquis' exchange platform and associated technology and systems are capitalised. Management reviews the time spent by the development team in developing and maintaining the systems used internally by Aquis when determining the amount to be capitalised within each period.

Critical accounting estimates

The key assumptions concerning the future, and other key sources of estimation uncertainty at the reporting date that may have a significant risk of causing a material adjustment to the carrying amounts of assets and liabilities within the next financial year, are discussed below.

Estimating the useful life of intangible assets

The expected useful life of most intangible asset is estimated to be 3 years, but some intangible assets are considered to have an indefinite useful economic life. In making this judgement management have taken into account product upgrade cycles, the pace of change of regulation as well as benchmarking against other companies with internal systems and technology research and development. Intangible assets with indefinite lives are reviewed for indicators of impairment at the end of each accounting period.

Expected credit loss of contract assets

An impairment for the expected credit loss of contract assets that arise as a result of applying IFRS 15 to licensing revenue is required under IFRS 9. This impairment is an accounting estimate which is calculated based on the Directors' best estimates of the probability of default and loss given default. The quantification of the assumptions and stresses for the year are disclosed in Note 11 of the financial statements.

In arriving at these estimates, the Directors have assessed the range of possible outcomes using reasonable and supportable forward-looking information, which is based on assumptions for the future movement of different economic drivers and how these drivers will affect each other.

Aquis' assessment of the credit risk associated with a licensing customer is conducted at inception of the contract (but before the user agreement is signed) and includes factors that are specific to the customer, general economic conditions and an assessment of both the current as well as the forecast direction of these conditions.

 

The credit risk assessment is conducted by means of a take-on assessment which comprises of a series of relevant criteria for a licensing contract that are scored according to the specific circumstances of the customer, with scores for each parameter typically ranging from 1-5. The assessment evaluates the following:

Level of funding;

Regulatory approvals;

Market, industry and business model;

Macro-economic forecasts;

Corporate governance/ Group management;

Whether the client is revenue generating;

Level of client profitability;

Contract length and the associated range of economic scenarios therein;

Payment history; and

External credit ratings.

The above assessment will determine the customer category upon inception of the contract, and the inputs to the expected credit loss model is determined thereon.

The credit risk assessment and associated inputs to the expected credit loss model (probability of default and loss given default) are critical assessments that could impact both the provision for expected credit losses as well as the movement in the provision reflected in the income statement.

Deferred tax asset

Deferred tax assets (Note 15) are recognised to the extent that their utilisation is probable. The utilisation of deferred tax assets will depend on whether it is possible to generate sufficient taxable income in the respective tax type and jurisdiction. A total net deferred tax asset is recognised in the current period, since profitability is expected to continue for at least the next 3 years. The deferred tax asset is calculated based on expected profitability over this period as Aquis is a high growth company and there is considerable uncertainty in estimating financial performance beyond this length of time.

Various factors are used to assess the probability of the future utilisation of deferred tax assets, including, operational plans and loss-carry forward periods. To reflect the uncertainty in the accuracy of business forecasts, the model uses modest growth rates and applies a probability weighting to each type of revenue.

 

Share-based payments

The US binomial model and Black Scholes model are used to estimate the fair value of the EMI, CSOP, RSP and PPO options. The resulting fair values are recognised over the vesting period as an expense in the Income Statement, with the corresponding amounts recognised as equity in the balance sheet. The model requires the following inputs: grant date, exercise price, expiry, expected life of options, expected volatility, and the risk-free interest rate. The expected life and expected volatility require the use of estimates. Volatility is estimated based on the historical average for the available data up to the grant date, while the expected life of the options is based on management's judgement of when the options will be exercised, which is assumed to be an average of 3-5 years.

 

5. Financial risk management

The Group seeks to protect its financial performance and the value of its business from exposure to adverse changes in capital commitments, as well as credit, liquidity and foreign exchange risks.

The Group's financial risk management approach is not speculative. The Group's Audit, Risk and Compliance Committee provides assurance that the governance and operational controls are effective to manage risks within the Board-approved risk appetite, supporting a robust Group risk management framework.

The Group's objectives when managing these risks are detailed below.

Capital risk management and capital commitments

Risk description

Risk management approach

There is a risk that Group entities may not maintain sufficient capital to meet their obligations. The Group comprises regulated entities. It considers that increases in the capital requirements of its regulated companies, or a scarcity of equity (driven by its own performance or financial market conditions) either separately or in combination are the principal risks to managing its capital.

 

AQXE has a total capital regulatory requirement of £6.2m as at 31 December 2024, with available capital of £24.9m, reflecting a surplus of £18.7m, or 301%. The total regulatory requirement is set as the total capital ratio plus Pillar 2 add on.

 

Within the AQSE subsidiary the capital regulatory minima are set by the FCA through the Financial Resource Requirement (FRR) which is currently set at £2.5m. Financial resources available (representing net assets) were £4.8m at 31 December 2023, reflecting a £2.4m headroom above regulatory minima.

Group's objectives when managing capital are to safeguard the Group's ability to continue as a going concern so that it can provide returns for shareholders and benefits for other stakeholders.

 

The Group has mitigated the level of risk significantly by ensuring that, as set out within the risk description, each entity in the Group maintains a level of capital that is well in excess of regulatory requirements. Maintaining a strong capital structure is a key priority for the Group. If there was an erosion of capital for any reason the Group may issue new shares or sell assets to ensure capital adequacy requirements continue to be met. The directors have assessed the impact of a 10% fall in the Group's available capital and concluded the impact not to be material.

 

The Group continuously monitors its level of capital in order to ensure it remains compliant with regulatory capital requirements and performs monthly and quarterly reporting on capital balances and associated headroom. Proposed investment requirements, capital expenditure and potentially increasing capital resources through equity or debt issuance are assessed annually as part of the budgeting process, as well as on an ad-hoc basis as required.

 

Credit risk

Risk description

Risk management approach

The Group's credit risk relates to its customers being unable to meet their obligations to the Group either in part or in full.

The Directors make a judgement on the credit quality of the Group's customers based upon the customers' financial position, the recurring nature of billing and collection arrangements and, historically, a low incidence of default.

 

Aquis' assessment of the credit risk associated with a licensing customer is conducted at inception of the contract (but before the user agreement is signed) and includes factors that are specific to the customer, general economic conditions and an assessment of both the current as well as the forecast direction of these conditions. Based on this assessment, the prospective customer is assigned to a customer category with an appropriate risk rating.

 

Aquis' credit risk management processes are applied to all trade receivables and are calculated using a lifetime ECL method, as detailed in Note 11. The Directors have stress tested the current approach to managing this risk and believe it to be appropriate.

 

If 10% of trade receivables outstanding from 31 December 2024 were to default, the hypothetical impairment charge would be £388k. This is compared to recognised provisions of £778k.

 

Liquidity Risk

Risk description

Risk management approach

The Group's operations are exposed to liquidity risk to the extent that they are unable to meet their daily payment obligations.

The Group maintains sufficient liquid resources to meet its financial obligations as and when they become due in the ordinary course of business. Management monitors forecasts of the Group's cash flow quarterly through an assessment of cash resources that are in excess of regulatory capital requirements. The Group is solvent with net current assets in excess of £15.9 million (2023: £17.2 million), with the majority of the debtor's book being short term in nature. The Group is also funded entirely by equity, with no external debt funding obligations to be met. The Directors have stress tested the current approach to managing this risk and believe it to be appropriate. If group net assets were to fall by 10% there would still be a significant surplus to meet the Group's liabilities as they fall due.

Interest Rate Risk

Risk description

Risk management approach

The Group is not materially exposed to market risk including interest rate (see below for FX risk).

 

There is no negative exposure to interest rate changes since the Group and Company have no external debt obligations, and the interest rate on the lease liability is the rate implicit in the lease and as such is not subject to change over the term of the lease.

Bank deposits are primarily placed for one week at a time. The Directors have stress tested the current approach to managing this risk and believe it to be appropriate. The only adverse impact would be if interest rates were to fall and reduce interest income on bank deposits. As at 31 December 2024 total interest income on deposits was £0.6 million (2023: £0.4 million).

 

FX Risk

Risk description

Risk management approach

The Group operates in the UK and Europe, with Sterling as its principal currency of operation. The Group invoices its customers primarily in GBP, but some contracts have been structured using USD and as such foreign exchange risk arises from invoicing in USD. The Group incurs the majority of expenses in GBP, but some costs are denominated in USD and EUR.

 

The value of the USD denominated contract is considered material to Group and Company's balance sheet. However, the foreign exchange exposure for costs invoiced in other currencies is considered immaterial.

 

An immaterial amount of cash held by Aquis Exchange Europe SAS is held in a euro denominated bank account and an immaterial amount of USD held by Aquis Exchange PLC, with the remaining cash held in Sterling denominated bank accounts.

 

Foreign exchange risk has previously arisen on foreign currency denominated costs within Aquis Exchange PLC or through the translation of GBP denominated balances within Aquis Exchange SAS. At the end of 2022 Aquis entered into a USD denominated technology contract and hence opened a USD account which holds a low level of USD at the year end £0.03 million (2023: £0.17 million). The contract delivers USD cash flows which are managed by use of USD forward strips.

 

As at the year end at 31 December 2024 the value of the FX forward was out of the money at £3,219 (2023: in the money at £51,407). The Directors performed stress testing on the cost base of the group in non-functional currencies and concluded that an adverse movement of 10% versus GBP would not render a material impact.

 

The statement of financial position is analysed below:

Group

Amortised

Cost

Fair Value through P&L

Fair Value through OCI

Non-financial instruments

Total in the Statement of Financial Position

31 December 2024

Trade and other receivables

9,347,423

-

-

1,475,893

10,823,316

Cash and bank balances

13,699,076

-

-

-

13,699,076

Investments

-

-

1,176,021

-

1,176,021

Provisions

-

-

-

(343,784)

(343,784)

Trade and other payables

(3,375,472)

-

-

(1,195,747)

(4,571,219)

Lease Liabilities

(2,549,566)

-

-

-

(2,549,566)

Derivatives

-

(3,219)

-

-

(3,219)

31 December 2023

Trade and other receivables

11,513,884

-

-

1,192,141

12,706,025

Cash and bank balances

14,765,910

-

-

-

14,765,910

Investments

-

-

591,945

-

591,945

Trade and other payables

(2,632,181)

-

-

(1,311,950)

(3,944,131)

Lease Liabilities

(2,984,444)

-

-

-

(2,984,444)

Derivatives

-

51,407

-

-

51,407

 

Company

Amortised

Cost

Fair Value through P&L

Fair Value through OCI

Non-financial instruments

Total in the Statement of Financial Position

31 December 2024

Trade and other receivables

10,215,685

-

-

1,365,682

11,581,367

Cash and bank balances

5,745,324

-

-

-

5,745,324

Investments

-

-

1,176,021

-

1,176,021

Provisions

-

-

-

(343,784)

(343,784)

Trade and other payables

(5,809,244)

-

-

(208,201)

(6,017,445)

Lease Liabilities

(2,172,188)

-

-

-

(2,172,188)

Derivatives

-

(3,219)

-

-

(3,219)

31 December 2023

Trade and other receivables

11,490,229

-

-

1,042,632

12,532,861

Cash and bank balances

6,356,259

-

-

-

6,356,259

Investments

-

-

591,945

-

591,945

Trade and other payables

(2,971,755)

-

-

(256,777)

(3,228,532)

Lease Liabilities

(2,537,883)

-

-

-

(2,537,883)

Derivatives

-

51,407

-

-

51,407

 

The following tables detail the Group and Company's remaining contractual maturity for its non-derivative financial liabilities with agreed repayment periods. The tables have been drawn up based on the undiscounted cash flows of financial liabilities based on the earliest date on which the Group or Company can be required to pay.

Group

1 Year

2-5 years

5+ years

Total

31 December 2024

Trade and other payables

4,571,219

-

-

4,571,219

Lease Liabilities

511,989

1,537,655

802,744

2,852,388

5,083,208

1,537,655

802,744

7,423,607

31 December 2023

Trade and other payables

3,956,088

-

-

3,956,088

Lease Liabilities

515,382

1,551,230

1,319,824

3,386,436

4,471,470

1,551,230

1,319,824

7,342,524

Company

1 Year

2-5 years

5+ years

Total

31 December 2024

Trade and other payables

6,017,445

-

-

6,017,445

Lease Liabilities

437,400

1,239,300

765,450

2,442,150

6,454,845

1,239,300

765,450

8,459,595

31 December 2023

Trade and other payables

3,228,532

-

-

3,228,532

Lease Liabilities

437,400

1,239,300

1,202,850

2,879,550

3,665,932

1,239,300

1,202,850

6,108,082

 

6. Operating segments

The Aquis Group can be split into four revenue streams, each offering multiple products and services and benefitting from Group synergies. The specific focus of these activities are:

(1) Aquis Markets - operator of MTF and related services. The Group operates two MTFs: Aquis Exchange ("AQXE"), which is UK regulated and Aquis Exchange Europe ("AQEU"), which is French regulated;

(2) Aquis Stock Exchange ("AQSE") - primary listings and trading business. Within this division is AQSE Main Market, AQSE Growth Market and AQSE Trading;

(3) Aquis Technologies - developer of exchange technology and services. The product offering includes Aquis Matching Engine, Aquis Market Surveillance, Aquis Market Gateway and related services including market surveillance and operations.

(4) Aquis Data - Market Data services across the MTF and Recognised Investment Exchanges operated by Group entities.

 

Aquis Exchange PLC is the parent company and comprises AQXE and Aquis Technologies. It owns 100% of its two subsidiaries, AQEU and AQSE. Management monitors the Group's overall performance regularly using a set of established Key Performance Indicators including Net revenue, and Adjusted EBITDA and Adjusted Profit Before Tax after exceptional costs. When monitoring the performance of each operating segment individually, management examines the discrete financial information available which will normally include revenue and gross profit for each division. Assets and liabilities, income tax and IFRS 2 charges are not reported internally to Chief Operating Decision Makers. In line with IFRS 8 the operating segments are reported separately as follows:

2024 Group

Aquis Markets

Aquis Stock Exchange

Aquis Technologies

Aquis Data

Total

Revenue

11,775,892

1,768,077

5,264,639

4,963,407

23,772,015

Impairment credit / (charge) on Contract Assets

-

-

(3,685,326)

-

(3,685,326)

Net revenue

11,775,892

1,768,077

1,579,313

4,963,407

20,086,689

Impairment (charge) on trade and other receivables

-

(100,839)

(601,598)

-

(702,437)

Other losses

(41,906)

(5,867)

(73,064)

(17,600)

(138,437)

Operating expenses before exceptionals

(7,539,513)

(1,383,705)

(3,491,016)

(3,327,542)

(15,741,776)

Share based payments

(653,353)

(105,753)

(294,398)

(289,490)

(1,342,994)

Adjusted EBITDA (before exceptionals)

3,541,120

171,913

(2,880,763)

1,328,775

2,161,045

Exceptional Recommended Offer costs

(1,676,678)

(239,436)

(717,591)

(710,158)

(3,343,863)

EBITDA

1,864,859

(67,523)

(3,598,354)

618,617

(1,182,818)

Depreciation, amortisation and net interest

(369,583)

(54,352)

(462,461)

(157,435)

(1,043,831)

Profit / (loss) before tax

1,494,859

(121,875)

(4,060,815)

461,182

(2,226,649)

Reconciliation of PBT to Adjusted PBT:

 

 

 

 

 

Profit / (loss) before tax

1,494,859

(121,875)

(4,060,815)

461,182

(2,226,649)

Exclude exceptional Recommended Offer costs

1,676,678

239,436

717,591

710,158

3,343,863

Adjusted profit / (loss) before tax

3,171,537

117,561

(3,343,224)

1,171,340

1,117,214

 

2023 Group

Aquis Markets

Aquis Stock Exchange

Aquis Technologies

Aquis Data

Total

Revenue

10,919,263

1,771,284

7,298,157

3,722,237

23,710,941

Impairment credit / (charge) on Contract Assets

-

-

(1,016,223)

-

(1,016,223)

Net revenue

10,919,263

1,771,284

6,281,934

3,722,237

22,694,718

Impairment (charge) on trade and other receivables

-

(19,787)

(58,108)

(1,500)

(79,395)

Other gains

-

-

51,407

-

51,407

Operating expenses

(7,134,010)

(1,634,472)

(3,550,170)

(2,992,168)

(15,310,820)

Share based payments

(499,963)

(81,102)

(334,162)

(170,431)

(1,085,658)

EBITDA (and Adjusted EBITDA)

3,285,290

35,923

2,390,901

558,138

6,270,252

Depreciation, amortisation and net interest

(292,793)

4,626

(583,951)

(203,247)

(1,075,365)

Profit before tax

2,992,497

40,549

1,806,950

354,891

5,194,887

The tables above represent the segment-level information that is monitored by the Chief Operating Decision Makers, which are the Chief Executive Officer, Chief Operating Officer and the Chief Financial Officer. All non-current assets (contract assets) are held centrally by Aquis Exchange PLC, other than the lease for the Paris office assigned to AQEU. The geographical analysis of the non-current assets is as follows; UK: £7,135k, Singapore: £2,754k and South Africa: £1,675k, Total: £11,564k.

At a Group level revenue from any one customer does not exceed 10% of total Group Revenue (2023: none). At a Company level revenue from one technology licence customer exceeded 10% of total Company revenues, and amounted to £3,100k (2022: two customers totalled £4,171k).

 

2024 Company

Aquis Markets

Aquis Stock Exchange

Aquis Technologies

Aquis Data

Total

Revenue

3,789,253

-

5,264,639

2,626,926

11,680,818

Impairment credit / (charge) on Contract Assets

-

-

(3,685,326)

-

(3,685,326)

Net revenue

3,789,253

-

1,579,313

2,626,926

7,995,492

Impairment (charge) on trade and other receivables

-

-

(601,598)

-

(601,598)

Other gains

(41,906)

(5,867)

(73,064)

(17,600)

(138,437)

Operating expenses before exceptionals

(56,816)

-

(3,491,016)

(1,131,843)

(4,679,675)

Share based payments

(653,353)

(105,753)

(294,398)

(289,490)

(1,342,994)

Adjusted EBITDA (before exceptionals)

3,037,178

(111,620)

(2,880,763)

1,187,993

1,232,788

Exceptional Recommended Offer costs

(1,652,335)

(239,436)

(717,591)

(710,158)

(3,319,520)

EBITDA

1,384,843

(351,056)

(3,598,354)

477,835

(2,086,732)

Depreciation, amortisation and net interest

(687,589)

(54,352)

(462,461)

(157,435)

(1,361,837)

Profit / (loss) before tax

697,254

(405,408)

(4,060,815)

320,400

(3,448,569)

Reconciliation of PBT to Adjusted PBT:

 

 

 

 

 

Profit / (loss) before tax

697,254

(405,408)

(4,060,815)

320,400

(3,448,569)

Exclude exceptional Recommended Offer costs

1,652,335

239,436

717,591

710,158

3,319,520

Adjusted profit / (loss) before tax

2,349,589

(165,972)

(3,343,224)

1,030,558

(129,049)

 

2023 Company

Aquis Markets

Aquis Stock Exchange

Aquis Technologies

Aquis Data

Total

Revenue

3,994,208

-

7,298,157

1,854,974

13,147,339

Impairment credit / (charge) on Contract Asset

-

-

(1,016,223)

-

(1,016,223)

Net revenue

3,994,208

-

6,281,934

1,854,974

12,131,116

Impairment (charge) on trade and other receivables

-

-

(58,108)

(1,500)

(59,608)

Other gains

-

-

51,407

-

51,407

Costs

(742,211)

-

(3,550,170)

(1,496,084)

(5,788,465)

Share based payments

(499,963)

(81,102)

(334,162)

(170,431)

(1,085,658)

EBITDA (and Adjusted EBITDA)

2,752,034

(81,102)

2,390,901

186,959

5,248,792

Depreciation, amortisation and net interest

(579,451)

4,626

(583,951)

(101,624)

(1,260,400)

Profit before tax

2,172,583

(76,476)

1,806,950

85,335

3,988,392

 

7. Employees

The monthly average number of persons (including directors) employed by the Group during the year was:

Group

2024

Number

2023

Number

Management

3

3

IT

30

23

Compliance and Surveillance

14

13

Operations

8

8

Business Development

21

21

Finance / HR / Admin

6

5

Marketing

2

2

84

75

Company

2024

Number

2023

Number

Management

2

2

IT

27

21

Compliance and Surveillance

7

6

Operations

8

8

Business Development

14

13

Finance / HR / Admin

5

5

Marketing

2

2

65

57

Group

2024

£

2023

£

Salaries and wages

8,459,538

7,523,034

Social security costs

1,085,216

1,056,857

Defined contribution pension costs

390,188

314,281

Share based payments

1,342,994

1,085,658

Employee benefits

243,248

238,727

11,521,184

10,218,557

 

Company

2024

£

2023

£

Salaries and wages

5,964,882

5,264,174

Social security costs

732,217

766,553

Defined contribution pension costs

268,239

207,351

Share based payments

1,342,994

1,085,658

Employee benefits

237,483

238,723

8,545,815

7,562,459

8. Retirement benefit scheme

Defined contribution schemes

The Group operates a defined contribution pension scheme for all qualifying employees. The assets of the scheme are held separately from those of the Company in an independently administered fund.

A defined contribution plan is a pension plan under which the Group pays fixed contributions into a separate entity. The Group has no legal or constructive obligations to pay further contributions if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

The total cost at a Group and Company level for defined contribution schemes is included in note 7.

9. Directors' remuneration

Further details on Directors' remuneration are included within the Directors' Report.

Company

2024

£

2023

£

Short-term employee benefits

1,048,196

1,096,773

Additional salary in lieu of pension contributions

33,625

26,465

Remuneration disclosed above include the following amounts paid to the highest paid director:

2024

£

2023

£

Short-term employee benefits

387,330

419,001

Additional salary in lieu of pension contributions

18,500

14,000

There are no directors to whom retirement benefits are accruing in respect of qualifying services. No directors exercised share options in the year (2023: none).

10. Revenue

An analysis of the Group's revenue by product for each segment is as follows:

2024 Group

Aquis Markets

Aquis

Technologies

Aquis Data

Aquis Stock

Exchange

Total

Exchange fees

11,775,892

-

-

636,401

12,412,293

Licence fees

-

5,264,639

-

-

5,264,639

Data vendor fees

-

-

4,963,407

-

4,963,407

Issuer fees

-

-

-

1,131,676

1,131,676

Total

11,775,892

5,264,639

4,963,407

1,768,077

23,772,015

2023 Group

Aquis Markets

Aquis

Technologies

Aquis Data

Aquis Stock

Exchange

Total

Exchange fees

10,919,263

-

-

663,068

11,582,331

Licence fees

-

7,298,157

-

-

7,298,157

Data vendor fees

-

-

3,722,237

-

3,722,237

Issuer fees

-

-

-

1,108,216

1,108,216

Total

10,919,263

7,298,157

3,722,237

1,771,284

23,710,941

2024 Company

Aquis Markets

Aquis

Technologies

Aquis Data

Aquis Stock

Exchange

Total

Exchange fees

3,789,253

-

-

-

3,789,253

Licence fees

-

5,264,639

-

-

5,264,639

Data vendor fees

-

-

2,626,926

-

2,626,926

Issuer fees

-

-

-

-

-

Total

3,789,253

5,264,639

2,626,926

-

11,680,818

2023 Company

Aquis Markets

Aquis

Technologies

Aquis Data

Aquis Stock

Exchange

Total

Exchange fees

3,994,208

-

-

-

3,994,208

Licence fees

-

7,298,157

-

-

7,298,157

Data vendor fees

-

-

1,854,974

-

1,854,974

Issuer fees

-

-

-

-

-

Total

3,994,208

7,298,157

1,854,974

-

13,147,339

Revenues from customers attributable to each of the following countries was as follows:

 

Group

Company

2024

£

2023

£

2024

£

2023

£

Country

Australia

74,081

57,000

42,444

33,567

British Virgin Islands

44,961

3,625

-

-

Canada

40,023

4,150

-

-

Cayman Islands

18,563

-

-

1,422

China

42,051

142,000

21,000

-

Colombia

233,183

39,329

233,183

-

Cyprus

9,281

-

-

-

Denmark

39,353

32,238

15,105

-

Finland

30,000

24,000

19,650

-

France

1,347,201

1,215,591

504,208

179,094

Germany

425,293

425,349

144,369

106,432

Gibraltar

13,931

4,000

-

-

Guernsey

21,222

2,100

-

-

Hong Kong

30,000

24,000

19,650

105,681

Hungary

43,490

35,000

3,033

-

Ireland

1,677,677

1,517,301

584,719

103,278

Isle of Man

28,144

825

-

-

Italy

35,000

24,000

22,925

-

Jersey

38,025

1,300

-

-

Kenya

21,006

14,150

-

-

Luxembourg

-

2,177

-

21,336

Netherlands

354,858

158,239

146,517

54,841

New Zealand

12,037

-

-

-

Norway

49,390

38,025

-

-

Singapore

220,506

483,311

220,506

-

South Africa

119,626

109,245

109,245

109,245

Spain

106,106

79,872

13,844

-

Sweden

30,000

24,000

19,650

7,965

Switzerland

214,277

222,330

87,068

113,107

Taiwan

9,281

-

-

-

United Arab Emirates

9,281

-

-

-

United Kingdom

15,676,421

17,432,294

7,719,768

10,920,149

United States

2,757,747

1,595,490

1,753,934

1,391,222

23,772,015

23,710,941

11,680,818

13,147,339

Subscription fees and data vendor fees:

Subscription fees and some data vendor fees are accounted for under IFRS 15 and are all recognised at point in time as they reflect variable revenue determined on a monthly basis. In addition to the variable monthly fee some AQSE data vendors pay an annual fee for access to real time and/or end of day data, which is recognised over time as the performance obligation of providing data is fulfilled.

The Group begins to recognise monthly subscription fees, data vendor fees, and connectivity fees when the customer conformance test is satisfactorily concluded, and an acceptance certificate is issued. This is then verified by the customer starting to utilise the platform, which is the point in time that the Group determines that the customer has received the benefit from the service.

In the case of subscription, connectivity and data fees, invoices are raised monthly in arrears and there is no obligation for a refund, return or any other similar obligation. There is no constrained variable consideration in any customer contracts, and the transaction price is allocated in full at a single point in time when the customer receives the benefit from the services.

Licence fees and contract assets:

Aquis Exchange PLC provides technology services under licence to clients. The services comprise the provision of an exchange platform and / or a surveillance system and may also include support services comprising basic infrastructure support or additional services. The duration of the licences varies between 1 and 7 years and will consist of an implementation fee, and, post implementation, a monthly licence fee for the duration of the contract. The monthly fees also cover system maintenance and system upgrades that typically occur every 12 - 18 months. The licensing contracts are accounted for under IFRS 15 and any corresponding contract assets are subject to IFRS 9 provisioning, as disclosed further in Note 11. Contract liabilities arise when consideration has been provided to Aquis prior to completion of relevant performance obligations as outlined below. These balances typically arise when customers pay in advance of implementation. As of the balance sheet date there are no contract liabilities (2023: nil).

The revenue from licensing contracts with customers has been categorised reflecting the nature, amount, customer categorisation (see also Note 4), contract duration and uncertainty of revenue and cash flows. Revenue from licensing contracts is assessed for each contract and is recognised as and when each performance obligation is satisfied. A transaction price is determined by the contractual terms of an agreement. Transaction prices are allocated to each performance obligation based on the standalone price of the product or service offered by the Group. The list of performance obligations included within Aquis' Technology Licence agreements is outlined below.

For licensing contracts, the Company has assessed the expected credit loss of each client individually. The transaction price is allocated according to the Group's obligations to the client over the course of licence period. There is no constrained variable consideration in any customer contracts.

The licensing fees line item also includes connectivity fees for licensing contract customers that are recognised at a point in time as they reflect variable revenue determined on a monthly basis and are underpinned by a separate agreement.

Contract Assets (Group and Company)

2024

£

2023

£

As at 1 January

8,480,444

6,114,105

PO2: Licence fees

3,670,000

5,419,476

PO3: Maintenance fees

680,648

449,533

ECL provisions on contract assets

(3,535,326)

(1,016,223)

Transfers to trade receivables

(3,071,416)

(2,345,265)

Adjustments for foreign exchange gains

21,963

(141,182)

As at 31 December

6,246,313

8,480,444

In the prior year the scope of a Technology Licence contract was amended resulted in cumulative catch- up adjustments of £86,400 being recognised despite satisfaction of their performance obligation in prior periods.

 

Upon invoicing of revenues the right to consideration becomes unconditional and thus contract asset balances have been reduced for balances transferred to trade receivables. The unrecovered amount included in receivables is £1,430,033 (2023: £626,607).

Performance obligation (PO)

Recognition of revenue upon completion

PO1: Implementation fees

Implementation/ project fees are upfront, non-refundable fees that a customer pays in order to obtain the user agreement. Even if the user acceptance certificate is never issued, the implementation fee cannot be reclaimed and so the revenue is guaranteed and can be recognised at the time of invoice as Aquis becomes unconditionally entitled to payment.

 

PO2: Licencing fees

At a point in time upon signing the user acceptance agreement, as the Company has fulfilled its promise to deliver the licence (i.e. the system has been deployed in the client's production environment). A corresponding contract asset (trade receivable) is recognised to reflect the customer's obligation to pay the monthly licensing fee over the remaining term of the contract.

 

PO3: Maintenance fees

Over the course of the licensing contract, as the performance obligation to maintain the system is settled and the customer benefits from using the system.

 

PO4: Live services fees

Over the course of the licensing contract, as the performance obligation to provide surveillance and similar core market operations tasks are settled and the customer benefits over time.

 

PO5: Hosting fees

Over the course of the licensing contract, as the performance obligation to use Aquis' hardware and infrastructure is used over time by the customer.

 

 

The aggregate amount of the transaction price per customer category that has been allocated to the performance obligations for the year is as follows:

2024

Group and Company

£

£

£

£

£

£

Risk Category1

1

2

3

4

5

Total

PO1

240,658

-

50,000

-

-

290,658

PO2

-

2,925,000

745,000

-

-

3,670,000

PO3

239,583

296,861

125,000

19,204

-

680,648

PO4

-

-

84,834

-

-

84,834

PO5

-

252,000

-

-

-

252,000

 

480,241

3,473,861

1,004,834

19,204

-

4,978,140

2023

Group and Company

£

£

£

£

£

£

Risk Category1

1

2

3

4

5

Total

PO1

65,000

500,000

280,630

-

-

845,630

PO2

2,550,000

2,027,500

85,586

756,390

-

5,419,476

PO3

62,457

239,453

125,000

22,623

-

449,533

PO4

-

-

-

-

-

-

PO5

-

42,000

-

-

-

42,000

 

2,677,457

2,808,953

491,216

779,013

-

6,756,639

The amount of revenue to be recognised from unsatisfied performance obligations with Technology Licence customers is as follows:

Group and Company

2024

2025

2026

2027-2030

Total

As at 31 December 2024

£

£

£

£

£

PO3

613,449

604,395

519,434

672,655

2,409,933

Group and Company

2023

2024

2025

2026-2029

Total

As at 31 December 2023

£

£

£

£

£

PO3

671,465

437,931

437,931

823,254

2,370,581

1 Customer risk category definitions: 1 - High, 2 - Moderately High, 3 - Moderate, 4 - Moderately Low, and 5 - Low.

 

11. Impairment

The Group has two types of financial asset that are subject to potential impairment, these are contract assets relating to technology licencing contracts and also trade receivables. At a Company level intercompany balances are assessed for any ECL on outstanding receivables arising during the normal course of business between the Parent and its subsidiaries.

The Group have concluded that trade receivables and contract assets have different risk characteristics and therefore the Expected Credit Loss (ECL) rates for each type of asset are measured separately. Since they comprise a portfolio of only a small number of clients, contract assets have been assessed on a client-by-client basis, whilst trade receivables have been grouped based on shared credit risk characteristics and the days past due. Further details on both methodologies can be found below.

IFRS 9 provisioning is applied to technology licensing contract assets based on management estimates of the recoverability of contracts over their useful life, and which are re-assessed at each renewal and also at each year-end.

The Group applies the IFRS 9 simplified approach to measuring expected credit losses which uses a lifetime expected loss allowance for trade receivables and contract assets and therefore the ECL for each contract is assessed on a lifetime basis rather than at each reporting date. As the simplified approach is adopted it is not necessary to consider the impact of a significant increase in credit risk.

Group

Company

Contract Assets

£

Trade Receivables

£

Contract Assets

£

Trade Receivables

£

Reconciliation of opening to closing loss allowances 2024

Opening Impairment Provision at 1 January

2,363,501

103,503

2,363,501

58,108

Impairment charge / (credit)

ECL on new contract assets

2,822,950

-

2,822,950

-

ECL increased over time

862,376

702,437

862,376

601,598

Net ECL movement

3,685,326

702,437

3,685,326

601,598

Foreign exchange on ECL balances

12,590

-

12,590

-

Total amounts recognised through profit or loss

3,697,916

702,437

3,697,916

601,598

Written-off financial assets

-

(28,053)

-

-

Closing Impairment Provision at 31 December

6,061,417

777,887

6,061,417

659,706

 

Group

Company

Contract Assets

£

Trade Receivables

£

Contract Assets

£

Trade Receivables

£

Reconciliation of opening to closing loss allowances 2023

Opening Impairment Provision at 1 January

1,347,278

58,953

1,347,278

-

Impairment charge / (credit)

ECL on new contract assets

1,729,154

-

1,729,154

-

ECL increased / (reversed) over time

(712,931)

79,395

(712,931)

59,608

Net ECL movement

1,016,223

79,395

1,016,223

59,608

Foreign exchange on ECL balances

-

-

-

-

Total amounts recognised through profit or loss

1,016,223

79,395

1,016,223

59,608

Written-off financial assets

-

(34,845)

-

(1,500)

Closing Impairment Provision at 31 December

2,363,501

103,503

2,363,501

58,108

Technology Licencing Contracts

During contract negotiation Aquis assesses the potential credit risk of a prospective client prior to committing to the contract, and the Directors consider factors that are specific to the customer, general economic conditions and an assessment of both the current as well as the forecast direction of these conditions. Based on this assessment, the prospective customer is assigned to a customer category with an appropriate risk rating.

A probability of default (PD) occurring during the lifetime of the contract ranging from 0-100% is applied to each client based on the assigned risk category. The credit risk of Aquis' technology clients ranges from those that are in infant start up stages (i.e. riskier) to those that are highly liquid and solvent conglomerates (little to no risk). As such, the Directors view the range of PDs for the portfolio to be between 100% for those with the highest level of risk to 0% for those that are so near to a zero level of risk that the PD is zero in substance. The Directors are comfortable that the assigned PD is sufficiently accurate to reflect the elevated risk associated with each start up when considering the idiosyncratic circumstances and risk factors of each client. The portfolio of technology contracts held by Aquis have PDs that have an observable relationship with time, i.e. the PD will decrease each year as the contract progresses. The credit risk of the contracts is directly linked to the success of the business and its ability to raise capital, and each year as the business continues in operation the credit risk decreases.

 

The Loss Given Default (LGD) is also quantified on a customer-by-customer basis and is done through an assessment of the recovery rate the Directors anticipate will be applied to the customer in the event of liquidation. Currently the low number of technology clients allows Aquis to assess each contract individually on the appropriate credit risk category, and this is determined based on several factors including company specific factors and also any future macro- economic changes, the sensitivity to these potential changes and the impact that these may have on the recoverability of the outstanding debt.

Although the full risk assessment is completed only at the start of the contract, the Directors assess each contract at the balance sheet date to determine whether the level of ECL provision, based on LGD and PD at contract inception, remains appropriate. The Directors consider a variety of factors specific to each customer, such as past payment history, but also assess the intent and ability to settle contractual commitments over the remaining contractual term, examples of which include but are not limited to, availability and sources of funding, revenue generating activities and profitability, and ongoing communications with the customer. Further factors considered by the Directors throughout the contract term are included within Note 4 under critical accounting estimates.

The Contract Asset Impairment provision as at 31 December 2024 is £6,061k (2023: £2,364k) and has been calculated with reference to estimations based on the PD and LGD as described above for each individual contract taking into account the nature, amount, customer categorisation, contract duration and uncertainty of revenue and cash flows. The increase in the Contract Asset Provision includes specific provisions made against two technology customers totalling £3,039k to reflect a heightened risk of default. A further £611k of provisions were recognised against these two customers but against trade receivable balances. The total increase in provisions recognised against these customers was equivalent to £3,650k across both Contract Assets and Trade Receivables. £200k of impairment was also made against a new contract asset recognised in the year.

The contracts are short-to-medium term in length and, as at 31 December 2024, the average contract duration for the portfolio of technology contracts is 3.6 years. (2023: 3.4 years).

Intercompany receivables

In line with IFRS 9 the Company has considered the qualitative and quantitative characteristics of the risk of default by its subsidiaries on outstanding receivables. These are considered non-material, both in quantum and in nature given regular settlement of balances and sufficient liquidity in both subsidiaries to cover amounts due to the Parent.

Trade Receivables

The Group has applied a simplified Expected Credit Loss ("ECL") model on trade receivables where a risk of potential non-payment may arise. In doing so the Group has considered the probability of a default occurring over the contractual life of the financial asset on initial recognition of the asset. Trade receivables are measured at amortised cost and the calculated ECL provision is deducted from the gross carrying amount of the assets. When a trade receivable is determined to be uncollectible, it is written off against the provision account for trade receivables.

The simplified provision matrix presented below is based on historic default rates over the expected life of the trade receivables and is adjusted where appropriate for forward-looking estimates. The trade receivables balance is split into 8 separate categories depending on the age of each debt, ranging from 0 days past due to over 180 days past due. An appropriate estimation of the probability of default is applied to each category of debt, based on both historical default rates and expectations for the future.

All AQSE customers are assessed within a single credit risk category. In determining that the value of any potential AQXE and AQEU provision is immaterial the Directors have separated AQXE and AQEU customers into three distinct risk categories based on homogeneous characteristics for each customer class. The factors used to differentiate each credit risk category in AQXE and AQEU are primarily based on the liquidity pools of each customer class, payment history and profiles, in addition to regulated status. The assessment of AQXE and AQEU provisions as immaterial excludes specific provisions for technology asset trade receivables of £659,796 (2023: £58,108). This includes £611,131 of provisions booked against the two Technology Licence customers for which impairment provisions of £3,039,000 were recognised against Contract Asset Balances.

Alongside AQSE provisions the total Group Provision at the year end was £751,947 (2023: £103,503).

The key assumptions in calculating the ECL for trade receivables are that the probability of default increases with the age of the debt and that the debts are homogeneous, i.e. the credit risk assessment is based on age rather than by individual client. The expected loss rates are based on historical credit losses experienced and adjusted to reflect current and forward-looking information. AQSE trade receivables have been assessed to have a higher risk of impairment than the rest of the Group's trade receivables.

Trade receivables have payment terms of 30 days from the date of billing. For debts older than 180 days, debts are assessed on a case-by-case basis and are written off if there is no reasonable expectation of recovery. During the year a total of £28,053 (2023: £33,345) of trade receivables were written off relating to debts from companies that had ceased membership with AQSE and the contractual rights to cash flows from the financial assets were deemed to have expired.

 

The total loss allowance is calculated by applying the expected loss rate to the trade receivables balance in each age bucket. The total portion of the ECL balance relating to trade receivables as at 31 December 2023 was £409,585, of which £92,241 related to AQSE balances (31 December 2023: £45,395). The table below shows the allocation of provisions against AQSE Trade Receivables:

Group - 2024

Days past Due

0

1-2

30-5

60-89

90-124

125 - 149

150-17

Over 180

Total

Expected loss rate

0.5%

1.0%

3.0%

5.0%

10.0%

25.0%

50.0%

100%

Trade receivables

1,611,041

860,074

296,612

407,575

186,332

174,780

194,234

148,349

3,878,997

Expected loss

(865)

(975)

(1,318)

(9,008)

(1,254)

(275)

(660)

(79,015)

(93,370)

Specific provisions

(58,684)

(121,200)

(100,200)

(105,636)

(92,280)

(97,320)

(95,102)

(14,095)

(684,517)

Total Expected Credit Losses

(59,549)

(122,175)

(101,518)

(114,644)

(93,534)

(97,595)

(95,762)

(93,110)

(777,887)

Group - 2023

Days past Due

0

1-29

30-59

60-89

90-124

125 - 149

150-179

Over 180

Total

Expected loss rate

0.5%

1%

3%

5%

10%

25%

50%

100%

Trade receivables

1,672,343

473,581

606,221

151,123

118,799

17,303

18,500

79,073

3,136,943

Expected loss

(564)

(598)

(6,891)

(1,411)

(6,683)

(1,125)

(3,300)

(6,585)

(27,254)

Specific provisions

(14,400)

-

(32,120)

(14,400)

(509)

-

-

(14,820)

(76,249)

Total Expected Credit Losses

(14,964)

(598)

(39,011)

(15,811)

(7,192)

(1,125)

(3,300)

(21,502)

(103,503)

 

12. Operating expenses, depreciation, amortisation, finance costs, and other gains and losses

Earnings before interest, taxation, depreciation and amortisation is stated after charging:

Group

Company

2024

£

2023

£

2024

£

2023

£

Other (losses)/gains

Fair value movements in Derivative Instruments

(54,626)

51,407

(54,626)

51,407

Loss on disposal of right of use assets

(83,811)

-

(83,811)

-

(138,437)

51,407

(138,437)

51,407

Other gains relate to fair value movements on derivative financial assets used to mitigate foreign currency risk. Please see Note 5, Financial Risk Management, for further details.

Group

Company

2024

£

2023

£

2024

£

2023

£

Administrative Expenses

Fees payable to the company's auditor for the audit of the company's financial statements

286,500

270,000

216,500

205,000

Fees payable to the company's auditor for the Client Asset audit

11,000

10,700

11,000

10,700

Share-based payments

1,342,994

1,085,658

1,342,994

1,085,658

Exchange (gain)/loss

(174,769)

104,162

3,437

146,103

Employee costs

10,178,190

9,132,899

7,202,821

6,476,801

Operating costs

5,440,855

5,793,059

4,690,066

5,317,912

Net intercompany income

-

-

(7,444,149)

(6,368,051)

17,084,770

16,396,478

6,022,669

6,874,123

Other administrative expenses comprise marketing fees, data centre and other service fees incurred in the ordinary course of business.

The Group expends resources to build trading platforms for its own use and for licencing to customers. Research and development costs that are not eligible for capitalisation have been expensed in the period incurred and are recognised in administrative expenses. In 2024 the amount recognised in the income statement was £821,080 (2023: £512,543).

 

Profit before taxation is stated after charging:

Group

Company

2024

£

2023

£

2024

£

2023

£

Depreciation, amortisation and finance costs

Depreciation of property, plant and equipment

832,284

760,308

762,279

687,019

Amortisation of intangible assets

828,714

612,257

828,714

612,257

1,660,998

1,372,565

1,590,993

1,299,276

Group

Company

2024

£

2023

£

2024

£

2023

£

Finance expense on lease liabilities (Note 28)

84,256

103,249

71,705

88,571

Finance income on lease assets (Note 28)

(92,605)

(15,737)

(92,160)

(15,293)

Interest income on deposited funds

(608,818)

(384,712)

(208,701)

(112,154)

(701,423)

(400,449)

(300,861)

(127,447)

Total expenses were as follows:

Group

Company

2024

£

2023

£

2024

£

2023

£

Total expenses

18,128,601

17,471,843

7,384,506

8,134,523

13. Exceptional Recommended Offer Costs

During the year the following costs were incurred by the Group to prepare shareholders and other relevant stakeholders for the Rule 2.7 Announcement under the Takeover Code, as was recommended by the Directors Aquis exchange and accepted by shareholders by a majority vote on 20 December 2024.

These costs, labelled as 'Recommended Offer' costs in this Annual Report and Accounts, have been classified as exceptional due to the one-off nature which affects an understanding of the Group's underlying performance and business activities across multiple years.

Group and Company

2024

£

2023

£

Exceptional Recommended Offer costs

Staff costs

536,722

-

Other operating expenses

2,807,141

-

3,343,863

-

Staff Recommended Offer costs include retention-based remuneration paid to all employees and time-based compensation for key personnel in supporting the Rule 2.7 Announcement.

Other expenditure includes legal and professional fees incurred for advice provided to the firm. Such costs incurred to date do not include completion-based fees which would be payable on successful completion of the deal.

Please refer to Note 2 for information about the classification of costs as exceptional.

14. Share-based payments

Aquis Exchange PLC has five different share schemes which have been set up since incorporation.

Aquis Exchange PLC has established two Trusts (see Note 22) to which it has provided funding to allow the purchase of shares for future settlement of the liability arising from the share awards noted below.

The Fair Value of any awards made in the year is calculated and recognised through the P&L over the appropriate period as set out in the detail on each scheme below. The total costs recognised through the P&L in the Group in 2024 was £1,343k (2023: £1,086k).

Group and Company

2024

£

2023

£

Enterprise Management Incentives (EMI) scheme

-

11,479

Restricted Share Plan (RSP) scheme

412,369

540,304

Company Share Ownership Plan (CSOP) scheme

52,387

57,963

Premium Priced Option (PPO) scheme

673,268

299,643

Share Incentive Plan (SIP) scheme

204,970

176,269

 

1,342,994

1,085,658

The aggregate level of share options and shares awarded which existed at the year end is 4,707,739 shares (2023: 3,526,785 shares).

Group and Company

2024

2023

Enterprise Management Incentives (EMI) scheme

809,961

899,378

Restricted Share Plan (RSP) scheme

461,943

416,572

Company Share Ownership Plan (CSOP) scheme

256,796

203,530

Premium Priced Option (PPO) scheme

2,859,017

1,745,443

Share Incentive Plan (SIP) scheme

320,022

261,862

 

4,707,739

3,526,785

 

Enterprise Management Incentive Plan

There is one approved EMI scheme, which was initiated in June 2018 when the first 564,124 options were granted. In April 2020 the second allotment (approved in and deferred from November 2019 because Aquis was in a close period) was made with a total of 740,250 options being granted. Options vest in 3 equal tranches, one, two and three years after grant. The options expire after 10 years.

The Group has estimated the fair value of options using a US binomial option valuation model and spread the estimated value against the profit and loss account over the life of the vesting period.

Of the total number of options granted, 85,750 (2022: 7,333) were exercised, none (2022: Nil) expired and none (2023: none) were forfeited during 2024.

The share price on the grant date was £2.69 and each option can be exercised at £2.69 to be settled in cash. The weighted average remaining contractual life of options outstanding at the end of the reporting period amounted to nil months (2023: nil).

The US binomial model with an average expiry duration of 5 years, volatility of 24% and risk-free interest rate of 1.1067% was used to calculate the fair value of the options granted on 14 June 2018. All options are exercisable at a price of £2.69 and the weighted average expected life of the options was estimated to be 5 years.

For options granted on 16 April 2020 the share price on the grant date was £3.47 and each option can be exercised at £3.47 to be settled in cash. The weighted average remaining contractual life of options outstanding at the end of the reporting period amounted to nil (2023: 3.5 months).

The US binomial model using an average expiry duration of 5 years, volatility of 20% and risk-free interest rate of 0.16% was used to calculate the fair value of the options granted on 16 April 2020. All options are exercisable at a price of £3.47 and the weighted average remaining expected life of the options was estimated to be 5 years.

Details of the EMI scheme are as follows:

2024

2023

Number of

Shares

Weighted average exercise price (£)

Number of

Shares

Weighted average exercise Price (£)

Outstanding at the beginning of the period

 

895,711

3.29

903,044

3.30

Exercised

 

(85,750)[1]

3.47

(7,333)[2]

3.47

Outstanding at the end of the period

 

809,961

3.28

895,711

3.29

Exercisable at the end of the period

 

809,961

3.28

895,711

3.29

 

Restricted Share Plan

The Group implemented a Restricted Share Plan (RSP) senior executive option scheme in 2020. Total grants were made in April 2024 of 85,958 at a grant price of £4.17 (April 2023: 70,637 options at a grant price of £4.01).

Options vest three years after grant, with an additional hold period of a further 2 years for executive directors and expire after 10 years.

The Black-Scholes model with an average expiry duration of 3 years, volatility of 21% and risk-free interest rate of 1.669% was used to calculate the fair value of the options granted in April 2022.

The Black-Scholes model with an average expiry duration of 3 years, volatility of 21% and risk-free interest rate of 1.891% was used to calculate the fair value of the options granted in September 2022. The weighted average remaining contractual life of options outstanding at the end of the reporting period amounted to 7 years and 7 months (2022: 7 years and 0 months).

For options granted on 26 April 2023 the share price at the date of grant was £4.03 and each option can be exercised at £0.10. The following inputs were used in the Black Scholes model: average maturity of 3 years, volatility of 23% and risk-free interest rate of 3.585%.

For options granted on 26 April 2024 the share price at the date of grant was £4.17 and each option can be exercised at £0.10. The following inputs were used in the Black Scholes model: average maturity of 3 years, volatility of 22.46% and risk-free interest rate of 4.185%. The fair value of the award was £329,599.

Details of the RSP scheme are as follows:

2024

2023

Number of

Shares

Weighted average exercise price (£)

Number of

Shares

Weighted average exercise Price (£)

Outstanding at the beginning of the period

 

407,496

4.71

341,364

4.85

Granted during the period

 

85,958

4.17

70,637

4.01

Forfeited during the period

 

(15,831)

4.44

(4,505)

4.03

Exercised during the period

 

(8,553)[3]

3.80

-

-

Expired during the period

 

(7,127)

3.80

-

-

Outstanding at the end of the period

 

461,943

4.65

407,496

4.71

Exercisable at the end of the period

 

207,709

4.95

137,706

3.64

 

Company Share Ownership Plan

The Group implemented a Company Share Ownership Plan (CSOP) employee option scheme in 2021. 62,942 options were granted in April 2024 and the share price at the date of grant was £4.17 each option can be exercised at £4.17 (April 2023: 64,322 options with a share price of £4.10 at the date of grant and can be exercised at £4.10).

Options vest three years after grant and expire after 10 years.

The Black-Scholes model with an average expiry duration of 5 years, volatility of 21% and risk-free interest rate of 1.669% was used to calculate the fair value of the options granted in April 2022. The weighted average remaining contractual life of options outstanding at the end of the reporting period amounted to 8 years and 1 months (2021: 7 years and 8 months).

The share price for the options granted on 26 April 2023 was £4.10 and each option can be exercised at £4.10. The following inputs were used in the Black Scholes model: average maturity of 3 years, volatility of 23% and risk-free interest rate of 3.585%.

The share price for the options granted on 26 April 2024 was £4.17 and each option can be exercised at £4.17. The following inputs were used in the Black Scholes model: average maturity of 3 years, volatility of 22.46% and risk-free interest rate of 4.185%. The fair value of the award was £45,636.

Details of the CSOP scheme are as follows:

2024

2023

Number of

Shares

Weighted average exercise price (£)

Number of

Shares

Weighted average exercise Price (£)

Outstanding at the beginning of the period

 

205,079

5.46

162,040

5.95

Granted during the period

 

62,942

4.17

64,322

4.10

Forfeited during the period

 

(11,225)

4.57

(21,283)

5.10

Exercised during the period

 

-

-

-

-

Expired during the period

 

-

-

-

-

Outstanding at the end of the period

 

256,796

5.18

205,079

5.46

Exercisable at the end of the period

 

81,266

6.85

-

-

 

Premium Priced Option Plan

The Group implemented a Premium Priced Option (PPO) option scheme in 2022 primarily focussed on Senior Executives. Grants in April 2024 were made amounting to 1,271,381 options at a grant price of £3.84 (April 2023: 1,138,512 at a grant price of £5.04).

Options vest 3 years after grant and expire after 7 years.

The Black-Scholes model with an average expiry duration of 5 years, volatility of 22.5% and risk-free interest rate of 1.5% was used to calculate the fair value of the options granted in June 2022. The weighted average remaining contractual life of options outstanding at the end of the reporting period amounted to 5 years and 6 months (2022: 6 years and 6 months).

For options granted on June 2022 the share price at the date of grant was £3.828 and each option can be exercised at £4.785. The following inputs were used in the Black Scholes model: average maturity of 5 years, volatility of 22.5% and risk-free interest rate of 1.79%.

The issue price for the options granted on 26 April 2023 is £4.03 per share to be settled in cash at the date of exercise at £5.0375. The following inputs were used in the Black Scholes model: average maturity of 5 years, volatility of 22.5% and risk-free interest rate of 3.723%.

The market value on the date of grant on 26 April 2024 was £4.28 and each option can be exerised at £4.80. The following inputs were used in the Black Scholes model: average maturity of 5 years, volatility of 22.46% and risk-free interest rate of 4.185%. The fair value of the award was £1,292,994.

Details of the PPO scheme are as follows:

2024

2023

Number of

Shares

Weighted average exercise price (£)

Number of

Shares

Weighted average exercise Price (£)

Outstanding at the beginning of the period

 

1,692,933

4.95

554,421

4.79

Granted during the period

 

1,271,381

3.84

1,138,512

5.04

Forfeited during the period

 

(105,297)

5.04

-

-

Exercised during the period

 

-

-

-

-

Expired during the period

 

-

-

-

-

Outstanding at the end of the period

 

2,859,017

4.46

1,692,933

4.95

Exercisable at the end of the period

 

-

-

-

-

 

Share Incentive Plan

The employee Share Incentive Plan ("SIP") is administered by Equiniti ("the Trust"). The Trust purchases shares in Aquis on the open market on behalf of employees that have elected to take part. Employees are limited to a maximum annual contribution of £1,800. The scheme allows employees to become shareholders in the Company in a tax efficient manner, with the Company purchasing two matching shares for every partnership purchased by the employee. The terms of the matching shares include that they must be held by the Trust for three years before they can be transferred or sold, and the employee must remain employed with the Company throughout this period. Free shares are also awarded to staff on an annual basis where performance criteria are met, with the Company purchasing up to a further 2 shares for each partnership share purchased.

The fair value of the matching and free shares purchased by the company are expensed over the three year vesting period. Management assumes that the cost of the shares is a close approximation of the fair value of the shares as the market price tends to be reflective of the discounted value of research analysts' medium-term projections.

The fair value of awards in the year was £204,970 (2023: £176,269).

Details of the SIP scheme are as follows:

2024

Number of Shares

2023

Number of Shares

Shares held at the beginning of the period

 

261,862

186,155

Partnership shares purchased in the period

 

15,313

16,863

Matching shares purchased during the period

 

30,626

33,726

Free shares purchased during the period

 

18,739

35,673

Exercised during the period

 

(5,806)

(2,607)

Forfeited during the period

 

(618)

(7,948)

Shares held at the end of the period

 

320,116

261,862

Exercisable at the end of the period

 

-

-

 

15. Deferred tax asset

A net deferred tax asset of £1,785,331 (2023: £1,785,331) at the Group and £1,506,022 (2023: £1,506,022 at the Company) relating to unused tax losses has been recognised in the current period. The losses are considered able to offset against the Company's taxable profits expected to arise in the next three accounting periods. This comprises a gross Deferred Tax Asset of £1,925,809 (2023: £1,884,349) at the Group and £1,646,500 (2023: £1,605,040 at the Company) offset by a Deferred Tax Liability of £140,478 (2023: £99,018) at the group and Company arising in the Company on the timing difference on accounting depreciation versus tax written down value charge.

The assessment of future taxable profits involves a significant degree of estimation, which management have based on the latest budget for the Company approved by the Board which reflects the improvement trading performance largely due to the continued expansion of the business as discussed in the Strategic Report. The preparation of the budget involves a rigorous review process by the Board, whereby each revenue stream and cost is scrutinised and challenged in detail so that the final version is considered to be an accurate and plausible representation of what is likely to be achieved in the period.

In calculating the deferred tax asset, Management have applied a conservative approach by using probability adjusted revenues, applying lower probabilities to budgeted revenue from more uncertain sources such as large technology licencing contracts, with the effect of reducing estimated profits over the 3-year period from the original forecasts. The analysis predicts profitability is still achievable even when revenues are reduced to reflect this adjustment.

The net deferred tax balance comprises temporary differences attributable to:

Group

2024

£

2023

£

Tax losses

1,925,809

1,884,349

Fixed asset timing differences

(140,478)

(99,018)

Total deferred tax asset

1,785,331

1,785,331

Company

2024

£

2023

£

Tax losses

1,646,500

1,605,040

Fixed asset timing differences

(140,478)

(99,018)

Total deferred tax asset

1,506,022

1,506,022

 

Movement in deferred tax balance:

Group

2024

£

2023

£

At 1 January

1,785,331

1,593,931

Origination and reversal of timing differences

(312,668)

270,485

Adjustment in respect of prior periods

312,668

(79,085)

At 31 December

1,785,331

1,785,331

Company

2024

£

2023

£

At 1 January

1,506,022

1,456,184

Origination and reversal of timing differences

(312,668)

122,556

Adjustment in respect of prior periods

312,668

(72,718)

At 31 December

1,506,022

1,506,022

Deferred tax assets are recognised only to the extent that there are sufficient probable future taxable profits available to set against deductible temporary differences and carry forward tax losses (and R&D credits). As at 31 December 2024 the Group and Company have not recognised deferred tax assets of £9,252,253 and £1,101,553 respectively (31 December 2023: £9,419,710 and £951,421) based on an assumed future tax rate of 25%. All tax losses in the Group do not have an expiry date.

The Group has combined losses of £44,150,335 (2023: £44,670,056) available for carry forward and to be used against future trading profits of the same trade in which they were generated. This is comprised of trading generated in the UK by Aquis Exchange PLC and Aquis Stock Exchange Limited. There are no losses carried forward in France within Aquis Exchange Europe SAS.

The Company has estimated losses of £10,430,300 (2023: £10,696,732) available for carry forward against future trading profits.

16. Income tax

Group

Company

2024

£

2023

£

2024

£

2023

£

Current Tax

UK Corporation tax charge

-

-

-

-

Overseas tax charges on foreign operations

235,291

183,611

-

-

Total current tax charge

235,291

183,611

-

-

Deferred Tax

Origination and reversal of timing

312,668

(270,485)

312,668

(122,556)

differences (Note 15)

Adjustment in respect of prior periods

(312,668)

79,085

(312,668)

72,719

Net income tax charge / (credit)

235,291

(7,789)

-

(49,837)

 

Reconciliation of expected tax charge / (credit) to (losses) / profits before tax:

Group

Company

2024

£

2023

£

2024

£

2023

£

(Loss) / Profit for the year before taxation

(2,226,649)

5,194,887

(3,448,569)

3,988,392

Expected tax charge based on a corporation tax rate of 25% (2023: 23.5%)

(792,517)

1,039,094

(862,142)

938,092

Expected tax charge based at effective overseas rates of 25.46% (2023: 25%)

230,244

182,100

-

-

Charge on disposal of right of use assets

21,941

(57)

21,941

(57)

Expenses not deductible for tax purposes

920,833

218,923

915,040

218,705

Adjustments in respect of prior periods

(312,668)

-

(312,668)

-

Other differences

-

857

-

(654)

Remeasurement of deferred tax for changes in tax rates

-

79,085

-

72,718

Movement in deferred tax not recognised

167,458

(1,527,791)

237,829

(1,278,641)

Tax charge / (credit) for the period

235,291

(7,789)

-

(49,837)

 

17. Earnings per share

Group

Company

2024

2023

2024

2023

Number of Shares

Weighted average number of ordinary shares for basic earnings per share

26,302,830

26,602,167

27,564,630

27,516,188

Weighted average number of ordinary shares for diluted earnings per share

27,113,586

27,491,871

28,375,386

28,405,822

Earnings

(Loss) / Profit for the year from continued operations

(2,461,940)

5,202,676

(3,448,569)

4,038,229

Basic and diluted earnings per share (pence)

Basic earnings per ordinary share

(9)

19

(13)

15

Diluted earnings per ordinary share

(9)

19

(12)

14

Basic earnings per share is in respect of all activities of the Group and diluted earnings per share takes into account the dilution effects which would arise on conversion or vesting of all outstanding share options and share awards under the Enterprise Management Incentive (EMI) scheme.

 

18. Intangible assets

Group and Company

Developed

trading platforms

 

Other Intangibles

Total Intangible

Assets

 

Group Goodwill

Cost

As at 1 January 2023

3,617,083

209,296

3,826,379

83,481

Additions

1,034,168

47,750

1,081,918

-

As at 31 December 2023

4,651,251

257,046

4,908,297

83,481

Additions

1,728,053

16,300

1,744,353

-

As at 31 December 2024

6,379,304

273,346

6,652,650

83,481

Accumulated amortisation and impairment

As at 1 January 2023

2,772,195

21,960

2,794,155

-

Charge for the year

559,741

52,516

612,257

-

As at 31 December 2023

3,331,936

74,476

3,406,412

-

Charge for the year

771,175

57,539

828,714

-

As at 31 December 2024

4,103,111

132,015

4,235,126

-

Carrying amount

As at 31 December 2024

2,276,193

141,331

2,417,524

83,481

As at 31 December 2023

1,319,315

182,570

1,501,885

83,481

All intangible assets within the Group are held by the Company.

Other intangible assets include assets valued at £68,835 (2023: £68,835) with indefinite useful economic lives. Further information on these assets can be found in Note 2 under the heading "Intangible assets other than Goodwill."

Goodwill

On 11 March 2020 the Group acquired Aquis Stock Exchange Limited (formerly NEX Exchange Limited) which resulted in recognition of goodwill of £83,481. The cash generating unit associated with the goodwill is determined to be the assets associated with the investment in AQSE.

The goodwill arising on consolidation represents the growth potential of the primary listings exchange and the synergies with the rest of the business. AQSE has no intangible assets.

Impairment tests for goodwill

Goodwill has been allocated for impairment testing purposes to a cash generating unit, being the net assets related to Aquis Stock Exchange.

The recoverable amounts of the cash generating unit has been determined based on a value-in-use calculation using discounted cash flow forecasts based on business plans prepared by management for a three-year period ending 31 December 2028. The two key estimates used in this model were an estimated terminal growth rate of 2%, and a pre-tax discount factor of 12%.

The results of the testing indicated the projected value of Aquis Stock Exchange to exceed its carrying value. As a result no impairment loss has been recognised in the current year.

19. Property, plant and equipment

Group

Fixtures, fittings and equipment

Computer Equipment

Right of Use Assets

Total

Cost

As at 1 January 2023

491,901

2,991,233

4,224,587

7,707,721

Additions

9,379

401,937

12,618

423,934

Foreign Currency Translation Differences

-

-

14,172

14,172

As at 31 December 2023

501,280

3,393,170

4,251,377

8,145,827

Additions (and lease adjustments)

4,549

383,380

-

387,929

Disposals

-

(10,909)

(113,003)

(123,912)

As at 31 December 2024

505,829

3,765,641

4,138,374

8,409,844

Accumulated amortisation and impairment

As at 1 January 2023

295,266

2,373,110

905,761

3,574,137

Charge for the year

50,731

325,755

383,822

760,308

Foreign Currency Translation Differences

-

-

(7,459)

(7,459)

As at 31 December 2023

345,997

2,698,865

1,282,124

4,326,986

Charge for the year

51,204

397,667

383,413

832,284

Disposals

-

(10,909)

(29,192)

(40,101)

As at 31 December 2024

397,201

3,085,623

1,636,345

5,119,169

Carrying amount

As at 31 December 2024

108,628

680,018

2,502,029

3,290,675

As at 31 December 2023

155,283

694,305

2,969,253

3,818,841

 

Company

Fixtures, fittings and equipment

Computer Equipment

Right of Use Assets

Total

Cost

As at 1 January 2023

477,130

2,984,386

3,656,087

7,117,603

Additions

9,379

400,352

-

409,731

As at 31 December 2023

486,509

3,384,738

3,656,087

7,527,334

Additions

4,549

383,380

-

387,929

Disposal

-

(10,909)

(113,003)

(123,912)

As at 31 December 2024

491,058

3,757,209

3,543,084

7,791,351

Accumulated amortisation and impairment

As at 1 January 2023

292,775

2,371,063

825,684

3,489,522

Charge for the year

47,782

323,341

315,896

687,019

As at 31 December 2023

340,557

2,694,404

1,141,580

4,176,541

Charge for the year

48,337

396,362

317,580

762,279

Disposal

-

(10,909)

(29,192)

(40,101)

As at 31 December 2024

388,894

3,079,857

1,429,968

4,898,719

Carrying amount

As at 31 December 2024

102,164

677,352

2,113,116

2,892,632

As at 31 December 2023

145,952

690,334

2,514,507

3,350,793

 

20. Investment in subsidiaries

Company

2024

£

2023

£

Investment in subsidiaries

6,884,202

6,884,202

Details of the Company's subsidiaries are set out in the following table. The investments are measured using the equity method in Aquis Exchange PLC's standalone accounts.

Name of undertaking

Country of

incorporation

Ownership interest (%)

Voting

power held (%)

Nature of

business

Carrying

amount 2024

Carrying

amount 2023

Aquis Stock Exchange

UK

100

100

Recognised Investment Exchange

3,677,118

3,677,118

Aquis Exchange Europe SAS

France

100

100

European Equities Exchange

3,207,084

3,207,084

6,884,202

6,884,202

The registered office of Aquis Exchange Europe SAS is 231 rue Saint Honoré, 75001 Paris, France. The registered office of Aquis Stock Exchange Limited is 63 Queen Victoria Street, EC4N 4UA,UK.

Both investments were assessed for impairment at year end and no indicators of impairment were noted, with both Aquis Stock Exchange and Aquis Exchange Europe SAS profitable in both 2024 and 2023. Therefore, in line with IAS 36 guidance, no impairment provision has been recognised in Aquis Exchange PLC's financial statements.

There has been no change in the year of the carrying value of any subsidiary (2023: no change).

21. Investments in financial assets

Group and Company

2024

£

2023

£

Financial assets measured at fair value through OCI

1,176,021

591,945

In August 2023 Aquis Exchange PLC acquired a 5.2% stake in OptimX LLC for consideration of USD 750k. The entity is currently in the development stage of creating blotter scraping technologies. The shares of OptimX LLC are not listed on any public market. A further investment of USD 750k was made in July 2024 bringing the Company's stake to 10.2%.

The fair value of OptimX, an unlisted-equity investment falls within Level 3 of the IFRS 13 Fair Value hierarchy, see Note 24 for further details on valuation of the investment.

 

22. Investment in Trusts

The table below shows the total amount the Company has invested in the two Trusts in respect of the share based payments arising under (i) the Employee Share Incentive Plan and (ii) the Restricted Share Plan, Company Share Ownership Plan and Premium Price Options plan as at the reporting date. Investments into the Trusts are mostly comprised of cash contributions made to acquire Company shares. Deductions from the Trusts represent vested shares withdrawn.

Company

2024

£

2023

£

Investment in Trusts

5,702,768

4,389,445

 

23. Trade and other receivables

Current

Non-current

Total

2024

2023

2024

2023

2024

2023

Group

£

£

£

£

£

£

Trade receivables

3,101,110

3,033,440

-

-

3,101,110

3,033,440

Technology licence contract assets

3,087,708

3,029,766

3,158,605

5,450,678

6,246,313

8,480,444

Other receivables

302,379

107,183

10,762

360,411

313,141

467,594

Prepayments

1,162,752

724,547

-

-

1,162,752

724,547

7,653,949

6,894,936

3,169,367

5,811,089

10,823,316

12,706,025

 

Current

Non-current

Total

2024

2023

2024

2023

2024

2023

Company

£

£

£

£

£

£

Trade receivables

2,717,502

2,538,127

-

-

2,717,502

2,538,127

Technology licence contract assets

3,087,708

3,029,766

3,158,605

5,450,678

6,246,313

8,480,444

Other receivables

270,550

44,970

-

345,240

270,550

390,210

Intercompany receivables

1,251,870

471,658

-

-

1,251,870

471,658

Prepayments

1,095,132

652,422

-

-

1,095,132

652,422

8,422,762

6,736,943

3,158,605

5,795,918

11,581,367

12,532,861

 

The following details the trade receivables that are stated net of any credit impairment provision, as set out previously in Note 11 in accordance with IFRS 9.

Group

Company

 

Trade receivables

2024

£

2023

£

2024

£

2023

£

Gross trade receivables

3,878,997

3,136,943

3,377,208

2,596,235

Expected credit loss on trade receivables

(777,887)

(103,503)

(659,706)

(58,108)

Gross contract assets

12,307,730

10,843,945

12,307,730

10,843,945

Expected credit loss on contract assets

(6,061,417)

(2,363,501)

(6,061,417)

(2,363,501)

Trade receivables net of provisions

9,347,423

11,513,884

8,963,815

11,018,571

24. Fair value measurement

Some of the Group's assets and liabilities are measured at fair value. In estimating the fair value of an asset or liability the Group uses market-observable data to the extent that is available.

All assets and liabilities for which fair value is measured or disclosed in the financial statements are categorised based on the lowest level input that is significant to the fair value measurement.

- Level 1: Quoted market prices in active markets for identical assets or liabilities;

- Level 2: Valuation techniques for which the lowest level input that is significant to the fair value measurement is directly or indirectly observable; and,

- Level 3: Valuation techniques for which the lowest level input that is significant to the fair value measurement is unobservable.

The policies and procedures for the valuation of unquoted financial assets determined by Management are presented to the Audit Risk and Compliance Committee at each relevant balance sheet date. The valuation of private equity instruments are particularly sensitive to changes in one or more unobservable inputs. Further information on the carrying amount of these assets and the sensitivity of those amounts to changes in unobservable inputs is provided below.

 

Group and Company

 

31 December 2024 assets and (liabilities)

Level 1

£

Level 2

£

Level 3

£

Derivatives, foreign currency forward contracts

-

(3,219)

-

Equity investments, OptimX LLC (Note 21)

-

-

1,176,021

-

(3,219)

1,176,021

 

Group and Company

 

31 December 2023 assets and (liabilities)

Level 1

£

Level 2

£

Level 3

£

Derivatives, foreign currency forward contracts

-

51,407

-

Equity investments, OptimX LLC (Note 21)

-

-

591,945

-

51,407

591,945

Reconciliation of fair value measurements categorised within level 3 of the fair value hierarchy:

 

 

2024

£

2023

£

Balance at 1 January

591,945

-

Acquisitions in the year

584,076

591,945

Gains and losses recognised in other comprehensive income

-

-

Balance at 31 December

1,176,021

591,945

No gains and losses were recognised in other comprehensive income for the year because the fair value of the investment in OptimX LLC at 31 December 2024 is materially consistent with the cost at acquisition.

Valuation Techniques and Inputs

Finance assets / liabilities

Valuation techniques and key inputs

Significant unobservable inputs

Relationship and sensitivity of unobservable inputs to fair value

Investment in unlisted shares, OptimX LLC (Note 21)

 

 

 

Income approach using the discounted cash flow method to determine the present value of future economic benefits derived from the investment.

 

 

 

Discount factor, determined by using a two year UK government gilt to determine a reasonable baseline for return on investment.

The greater the discount factor the lower the fair value.

 

If the discount rate was 5% higher/lower, with all other variables remaining constant, the carrying amount would decrease/increase by £173k / £227k.

Revenue growth rate

The higher the compound growth rate the higher the fair value.

If the growth rate were to increase /decrease by 0.5%, the carrying amount would increase/increase by £357k / £319k.

 

25. Cash and cash equivalents

Group

Company

2024

£

2023

£

2024

£

2023

£

Cash at bank

13,699,076

14,765,910

5,745,324

6,356,259

Cash and cash equivalents comprise over night and short term deposits of less than 3 month and are held with authorised counterparties of a high credit standing. Management does not expect any losses from non-performance by the counterparties holding cash and cash equivalents, and there are no material differences between their book and fair values.

Cash held by Aquis Exchange Europe SAS is predominantly held in a Sterling denominated bank account.

26. Provisions

Group and Company

 

Provisions for disputed data costs

2024

£

2023

£

Balance at 1 January

-

-

Provisions recognised in the year

343,784

-

Balance at 31 December

343,784

-

Provisions were raised in the year to provide against disputes over amounts due for data services received by the Group over the last few years which would be payable to two data vendors.

There remains uncertainty as to the final settlement amount because ongoing discussions with the vendors are yet to establish the scope of error. However, the amounts provided represent the Directors' best estimate of the liability based on current discourse with those entites at the date of signing these financial statements.

Provisions recognised in the Group and Company have not been discounted because final settlement is expected to occur within one year of the balance sheet date.

27. Trade and other payables

Group

Company

 

Current

2024

£

2023

£

2024

£

2023

£

Trade payables

1,122,893

759,002

1,088,349

674,307

Accruals

2,082,791

1,814,407

1,623,395

1,388,911

Deferred Revenue

786,658

934,423

-

-

Social security and other taxation

353,628

343,729

208,201

256,777

Intercompany payables

-

-

2,933,762

824,405

Other payables

169,788

58,772

163,738

84,132

Overseas corporation tax payable

55,461

33,798

-

-

Short term lease liabilities

511,989

527,339

437,400

437,400

Short Term Lease Liabilities

5,083,208

4,471,470

6,454,845

3,665,932

28. Leases

Right of Use Assets

The right-of use asset was measured at the amount equal to the lease liability, plus prepaid lease payments (being the unamortised portion of the rent deposit asset). The right of use asset is depreciated over the term of the lease and was accounted for during the year ended 31 December 2024 as follows:

Group

£

Company

£

Carrying amount at 1 January 2023

3,318,826

2,830,403

Remeasurement of Paris Lease

21,631

-

Foreign currency translation differences

12,618

-

Depreciation for the year

(383,822)

(315,896)

Carrying amount at 31 December 2023

2,969,253

2,514,507

Disposal of right of use assets

(83,811)

(83,811)

Depreciation for the year

(383,413)

(317,580)

Carrying amount at 31 December 2024

2,502,029

2,113,116

Rent deposit asset

The rent deposit asset (excluding the prepaid right of use portion which has been included in the calculation of the right of use asset above) is a financial asset measured at amortised cost and was accounted for during the year ended 31 December 2024 as follows:

Group

£

Company

£

Carrying amount at 1 January 2023

356,647

329,947

Recovery of rent deposit

(7,619)

-

Remeasurement of Paris lease

(4,354)

-

Finance income on rent deposit asset for the year

15,737

15,293

Carrying amount at 31 December 2023

360,411

345,240

Recovery of rent deposit asset

(442,254)

(437,400)

Finance income on rent deposit asset for the year

92,605

92,160

Carrying amount at 31 December 2024

10,762

-

 

Lease liability

The lease liability is calculated as the net present value of the fixed payments (including in-substance fixed payments), less any lease incentives receivable (such as any rent-free periods). The lease payments are discounted using the interest rate implicit in the lease. The lease liability is measured at amortised cost and was accounted for during the year ended 31 December 2024 as follows:

Group

£

Company

£

Carrying amount at 1 January 2023

3,410,193

2,886,712

Foreign currency translation differences

(12,516)

-

Finance expense on lease liability for the year

103,249

88,571

Lease payments made during the year

(516,482)

(437,400)

Carrying amount at 31 December 2023

2,984,444

2,537,883

Finance expense on lease liability for the year

84,256

71,705

Lease payments made during the year

(519,134)

(437,400)

Carrying amount at 31 December 2024

2,549,566

2,172,188

Of which are:

Current

511,989

437,400

Non-current

2,037,577

1,734,788

2,549,566

2,172,188

The non-current and current portions of the lease liability are included in 'Lease liability' and 'Other Payables' (Trade and Other Payables) on the Statement of Financial Position respectively.

Net finance (income) / expense on leases

Group

Company

2024

£

2023

£

2024

£

2023

£

Finance expense on lease liability

84,256

103,249

71,705

88,571

Finance income on rent deposit asset

(92,605)

(15,737)

(92,160)

(15,293)

Net finance (income) / expense relating to leases

(8,349)

87,512

(20,455)

73,278

The finance income and finance expense arising from the Groups leasing activities as a lessee have been shown net where applicable as is permitted by IAS 32 where criteria for offsetting have been met.

 

Amounts recognised in profit and loss

Group

Company

2024

£

2023

£

2024

£

2023

£

Depreciation expense on right-of-use assets

(383,413)

(383,822)

(317,580)

(315,896)

Finance expense on lease liability

(84,256)

(103,249)

(71,705)

(88,571)

Finance income on rent deposit asset

92,605

15,737

92,160

15,293

Short term lease expense

(12,451)

(43,310)

-

-

Loss on disposal of Right of Use Assets

(83,811)

-

(83,811)

-

Net impact of leases on profit or (loss)

(471,326)

(514,644)

(380,936)

(389,174)

The contractual terms of the Paris lease state that lease payments are indexed which has resulted in a remeasurement of the lease liability to reflect an uplift of future expected payments. The Company lease based in the UK is not subject to variable rates.

29. Share capital

Group

2024

£

2023

£

Ordinary share capital

Issued and fully paid

27,516,781 (2023: 27,509,448) Ordinary shares of 10p each

2,751,678

2,750,945

Issue of 7,333 new shares of 10p each

-

733

Issue of 85,750 new shares of 10p each

8,575

-

27,602,531 (2023: 27,516,781) Ordinary Shares of 10p each

2,760,253

2,751,678

 

30. Treasury shares

Group

2024

£

2023

£

At the beginning of the year

4,389,445

3,350,325

Purchase of additional shares

1,517,690

1,215,243

Shares vested or sold by trusts

(221,157)

(157,189)

Change in level of surplus cash held by trusts

16,790

(18,934)

At the end of the year

5,702,768

4,389,445

Treasury shares are held by the Employee Benefit Trusts. Further disclosures about the value of shares acquired by the EBT can be read in note 22. The Investment in Trust has been consolidated within the Group's results as the parent company (Aquis Exchange PLC) can substantially direct the investment activities of the Trusts, thus the Trusts' assets have been consolidated as Treasury Shares.

In the year to 31 December 2024 328,861 shares with a nominal value of £32,886 were bought at a total cost of £1,517,690 and held in Treasury (2023: 331,179 shares with a nominal value of £33,178 were bought at a total cost of £1,215,243 and held in Treasury).

As at 31 December 2024, 320,022 shares (2023: 261,956) were held in the Employee Share Incentive Plan Trust, and a further 1,110,970 shares (2023: 840,175) held in the Trust relating to Restricted Share Plan, Company Share Ownership Plan and Premium Priced Option Plan.

At 31 December 2024 £34,466, (2023: £17,676) of surplus cash was held within the Trusts, which had yet to be used to purchase Treasury shares, but remained under the control of the Trusts.

 

Group

2024

£

2023

£

Treasury Shares held

5,668,302

4,371,769

Cash Held in Employee Trusts

34,466

17,676

At the end of the year

5,702,768

4,389,445

 

31. Cash generated by operations

Group

2024

£

2023

£

(Loss) / Profit before tax

(2,226,649)

5,194,887

Adjustments for:

Impairment charge/(credit) on contract assets

3,685,326

1,016,223

Impairment charge on trade and other receivables

702,437

44,550

Fair value adjustment to derivatives

54,626

(51,407)

Equity settled share based payment expense

1,342,994

1,085,658

Amortisation of intangible assets

828,714

612,257

Depreciation and impairment of property, plant and equipment

832,284

760,308

Loss on disposal of right of use asset

83,811

-

Increase in provisions

343,784

-

Finance expense

84,256

103,249

Finance income

(92,605)

(15,737)

Interest income

(608,818)

(384,712)

7,256,809

3,170,389

Movement in working capital:

(Increase) in trade and other receivables

(2,919,643)

(4,277,113)

Increase in trade and other payables

617,858

309,470

Cash generated by operations

2,728,375

4,397,633

Corporation taxes paid

(203,312)

(293,914)

Net cashflow from operating activities

2,525,063

4,103,719

 

Operating cash flows

For the year ended 31 December 2024

Company

2024

£

2023

£

(Loss) / Profit before tax

(3,448,569)

3,988,392

Adjustments for:

Impairment charge/(credit) on contract assets

3,685,326

1,016,223

Impairment charge on trade and other receivables

601,598

58,108

Fair value adjustment to derivatives

54,626

(51,407)

Equity settled share based payment expense

1,342,994

1,085,658

Amortisation of intangible assets

828,714

612,257

Depreciation and impairment of property, plant and equipment

762,279

687,019

Loss on disposal of right of use asset

83,811

-

Increase in provisions

343,784

-

Finance expense

71,705

88,571

Finance income

(92,160)

(15,293)

Interest income

(208,701)

(112,154)

7,473,976

3,368,982

Movement in working capital:

(Increase)/Decrease in trade and other receivables

(3,680,670)

2,309,031

Increase/(Decrease) in trade and other payables

2,788,913

(5,326,269)

Cash generated by operations

3,133,650

4,340,136

Corporation taxes paid

-

-

Net cashflow from operating activities

3,133,650

4,340,136

 

32. Related party transactions

Remuneration of key management personnel

The remuneration of the directors, who are key management personnel, is set out below in aggregate for each of the categories specified in IAS 24 Related Party Disclosures.

Group

2024

£

2023

£

Salaries and other short term benefits

1,190,384

1,569,531

Share based payments

421,846

490,437

Total

1,612,230

2,059,968

Company

2024

£

2023

£

Salaries and other short term benefits

1,081,821

1,123,238

Share based payments

276,519

246,592

Total

1,358,340

1,369,830

During the year the Group has entered into, in the ordinary course of business, transactions with other related parties. All transactions between Aquis Exchange Plc and its subsidiaries are eliminated on consolidation.

Costs incurred by the Company on behalf of its subsidiary companies are recharged to these Companies through a Management fee and service charge, which for 2024 represented a net recharge of £6,600k (2023: £5,678k) to Aquis Europe SAS and a net recharge of £711k (2023: £690k) to Aquis Stock Exchange Limited. The net cash payments in the year and balances outstanding at the year end were:

2024

Company

Receipts and (payments)

£000s

Amounts owed

from related parties

£000s

Amounts owed

to related parties

£000s

Aquis Stock Exchange Ltd

3,192

170

(216)

Aquis Europe SAS

(1,697)

764

(2,718)

Total

1,495

934

(2,934)

2023

Company

Receipts and (payments)

£000s

Amounts owed

from related parties

£000s

Amounts owed

to related parties

£000s

Aquis Stock Exchange Ltd

2,565

551

-

Aquis Europe SAS

(1,385)

-

(904)

Total

1,180

551

(904)

33. Share premium account

Group

2024

£

2023

£

At the beginning of the year

11,809,757

11,785,045

Issue of new shares

288,977

24,712

At the end of the year

12,098,734

11,809,757

34. Other reserves

Group

Company

2024

2023

2024

2023

£

£

£

£

Reserves relating to share-based payments

3,863,426

2,741,589

3,863,426

2,741,589

35. Controlling party

In the opinion of the Directors, there is no single overall controlling party.

No individual shareholder had a shareholding of 10% or above as at 31 December 2024.

36. Events occurring after the reporting period

On 17 February 2025 Alasdair Haynes informed the Board of his decision to step back from the day-to-day running of the business for health reasons, and assumed the role of President of the Group. Alasdair remains a Director of the Company, acting as senior counsel to the management team.

On the same day David Stevens assumed the role of Chief Executive Officer and was appointed as a Director of the Company.

 


[1] For options exercised in 2024, the share price on the date of exercise was: 2,542 options at £3.62, 5,092 options at £3.65, 10,336 options at £3.60, 29,000 options at £3.62, and 38,750 options at £7.05.

[2] For options exercised in 2024, the share price on the date of exercise was: 7,333 options at £3.70.

[3] The share price on the date of exercise was £3.87.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FR UOARRVKUSAUR

Related Shares:

Aquis Exchange
FTSE 100 Latest
Value8,275.66
Change0.00